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ABSTRACT
Elucidating factors associated with adherence to treatment for physical and mental health
conditions is important, given well-documented associations between non-adherence and poor
treatment outcomes. Researchers have worked to identify such factors; however, most studies
focus on adherence to medical, rather than, psychological treatments. Clarifying variables that
predict adherence to psychotherapy is particularly important for individuals with post-traumatic
stress disorder (PTSD), for whom treatment, which typically involves exposure to trauma-related
stimuli and imagery, can be aversive. It may consequently be associated with high nonadherence rates, even though studies indicate that greater adherence to PTSD treatment relates to
better treatment outcomes. Research needs to identify factors that increase or decrease the
likelihood that affected individuals will enter and complete therapy.

Although several studies to date have examined adherence to treatment for PTSD, this
literature is limited on several fronts. First, studies on psychotherapy adherence have identified
few consistent predictors of treatment adherence. Second, adherence to psychotherapy is rarely a
central focus of treatment-related research; more typically, researchers treat adherence as
secondary in importance to treatment outcomes. Third, little research on psychotherapy
adherence has been theoretically driven. Fourth, little adherence research has focused on combat
veterans with PTSD, who tend to have particularly poor treatment outcomes. Especially lacking
is knowledge about predictors of adherence in veterans who have recently returned from combat;
most research focuses on veterans of the Vietnam War, many of whom were initially traumatized
decades earlier.
The study tested the hypothesis that elevated reports of a specific type of PTSD
symptom--avoidance/emotional numbing-- predicted poorer adherence to treatment in 160
veterans who received psychotherapy. No significant associations between avoidance and
emotional numbing symptoms and adherence were found. However, emotional numbing was
negatively related to psychotherapy adherence. Other variables typically related to PTSD and
treatment outcomes were found to be important predictors of psychotherapy adherence and
completion/noncompletion of therapy.
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CHAPTER 1.
INTRODUCTION
Mental health problems among combat veterans are widespread. Recent studies have
found that 25% of veterans who served in Operation Enduring Freedom (OEF) in Afghanistan
and/or Operation Iraqi Freedom (OIF) received one or more mental health-related diagnoses
(Seal, Bertenthal, Miner, Sen, & Marmar, 2007). More specifically, researchers have found a
high prevalence of depression and alcohol use disorders, both of which commonly co-occur with
post-traumatic stress disorder (PTSD), among OEF/OIF veterans (Hoge et al., 2004).
Furthermore, of those OEF/OIF veterans with identified mental health problems, 52% received a
diagnosis of PTSD (Seal, Bertenthal, Miner, Sen, & Marmar, 2007). OEF/OIF veterans are
clearly at high risk for developing PTSD or related symptoms (Hoge et al., 2004; Rundell, 2006).
Research on earlier samples of veterans suggests that this is especially true if they are young at
the time of the trauma, have limited education, faced childhood adversity, lack social support, or
experienced severe trauma (Brewin, Andrews, & Valentine, 2000).
Given the prevalence of PTSD among veterans it is not surprising that rates of mental
health treatment utilization are high for the disorder and related conditions. Recent findings, for
example, suggest that as many as 23 to 40% of veterans of recent conflicts have sought mental
health services from the Veterans Administration (VA) (Hoge, Auchterlonie, & Milliken, 2006;
Hoge et al., 2004). Many, however, fail to adhere to or to complete treatment after enrollment
(Schnurr et al., 2007). Reasons for the high rates of PTSD treatment non-adherence among
veterans are unclear. I designed the present study to investigate potential correlates of treatment
adherence in veterans of combat in the ongoing campaigns in Afghanistan and Iraq. More
specifically, I examined whether high levels of avoidance/emotional numbing symptoms related
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negatively to treatment adherence. To provide background and a rationale for the proposed
study, I first review the literature regarding the etiology and maintenance of PTSD, what works
in treating PTSD, and why individuals may fail to adhere to treatment for PTSD.
General Background on PTSD
PTSD, by definition, develops after exposure to a situation or event that is, or is
perceived to be, threatening to the safety or physical integrity of one’s self or of others. The
affected individual must also experience intense fear, helplessness, or horror during the
threatening event (APA, 2000). Given the frequency with which threats to safety arise in the
context of combat, high rates of PTSD among veterans are not surprising.
The disorder manifests as three types of symptoms: re-experiencing of the traumatic
event (e.g., recurrent and intrusive thoughts, distressing dreams, flashbacks),
avoidance/emotional numbing (e.g., avoidance of reminders of the event, restricted range of
affect), and hyperarousal (e.g., sleep difficulties, exaggerated startle response). To obtain a
diagnosis of PTSD, an individual must have at least one re-experiencing symptom, at least three
avoidance and emotional numbing symptoms, and at least two hyperarousal symptoms. Further,
the individual must be bothered by the symptoms for a month or more and must experience
significant distress or impairment in social, occupational, or other areas of functioning (APA,
2000).
PTSD is highly impairing, both in isolation and in the context of comorbidity with other
major psychological conditions such as substance abuse, major depression, and personality
disorders (Bremner, Southwick, Darnell, & Charney, 1996; Keane & Wolfe, 1990). Severity of
PTSD symptoms has been associated with the onset of medical problems including arterial,
dermatological, gastrointestinal, and musculoskeletal disorders (Schnurr, Spiro, & Paris, 2000).
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Social functioning difficulties are also apparent in individuals with PTSD; these include
interpersonal violence, social anxiety, marital/family issues, and occupational problems (Frueh,
Turner, Beidel, & Cahill, 2001; Schlenger, Kulka, Fairbank, & Hough, 1992).
For veterans who develop PTSD, it is not unusual for symptoms to arise during or shortly
after their tours of duty and to persist over long periods of time (Hoge et al., 2004; Rundell,
2006; Schlenger, Kulka, Fairbank, & Hough, 1992). The National Vietnam Veterans
Readjustment Study found that 15 or more years after combat had ended, 15% of veterans of the
Vietnam War met diagnostic criteria for current PTSD (Kulka et al., 1990; Schlenger, Kulka,
Fairbank, & Hough, 1992). Over decades, researchers have investigated the etiological
underpinnings of PTSD, which in turn has led to the development of multiple theoretical models.
Although rates of PTSD are high among veterans, not all individuals who witness or
experience traumatic events, such as those common in combat, develop the disorder or related
symptoms. Researchers, therefore, have begun to devise models to explain and predict risk for its
development and maintenance. Although PTSD is widely accepted to be multiply determined
and maintained (Barlow, 2002), a number of theorists have focused on specific factors, such as
maladaptive patterns of cognition and behaviors, that appear to contribute heavily to the disorder
and its persistence (Ehlers & Clark, 2000; Foa & Kozak, 1986). According to Ehlers and Clark
(2000), who developed a prominent cognitive model of persistent PTSD, affected individuals
think about, interpret, and re-experience traumatic events in ways that lead them continually to
perceive their environments as threatening, even when real threat cues are absent (see Figure 1).
Such misperceptions, in turn, lead them to engage in maladaptive behaviors, such as avoidance,
that may reduce distress in the moment, but contribute to persistent PTSD symptoms in the long
term by preventing the development of more adaptive thoughts and responses.

4

Negative Appraisal of Trauma and/or its
sequelae

Nature of Trauma Memory
Matching
Triggers

Current Threat
Intrusions
Arousal Symptoms
Strong Emotions

Strategies Intended to Control Threat/Symptoms
Arrows indicate the following
relationships:
Leads to
Influences
Prevents change in
Figure 1: Ehlers and Clark (2000) cognitive model of PTSD
Indeed, multiple researchers have suggested that avoidance is a primary obstacle to
changing negative appraisals and memories of traumatic events (Ehlers & Clark, 2000; Foa &
Kozak, 1986). There are three types of avoidance: cognitive, behavioral, and emotional.
Cognitive avoidance (e.g., “thought suppression”) is when an individual tries to avoid thinking
about trauma. This strategy may work in the short term, but tends over time to increase intrusive
recollection of traumatic experiences. Behavioral avoidance involves staying away from places
or things that elicit memories of a trauma. For example, a veteran with PTSD might avoid
watching war movies or the news (Ehlers & Clark, 2000). A third type of avoidance—
emotional—is not central to Ehlers’ and Clark’s model (2000), but has received attention as an
additional maladaptive coping strategy for PTSD (Foa et al., 1986; 1989). According to Foa and
colleagues, individuals with PTSD experience emotional discomfort when environmental cues
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activate their ‘fear structures’ (i.e., constellations of information about the traumatic event, their
own responses to the trauma, and the meaning of the event). To avoid this emotional discomfort,
affected individuals steer clear of reminders of the trauma. This avoidance may be voluntary, and
manifest as effortful suppression of trauma-related feelings, or involuntary, in which case it may
manifest as “numbing” or difficulty experiencing typical emotional responses (Ehlers & Clark,
2000; Foa, Steketee, & Rothbaum, 1989).
As Ehlers and Clark (2000) point out, avoidance of any type can interfere with the
successful treatment of PTSD. Exposure therapy, a well-supported treatment for PTSD (e.g.,
Bradley, Greene, Russ, Dutra, & Westen, 2005), challenges clients to relive traumatic
experiences in a controlled manner by engaging with, rather than avoiding, traumatic memories.
According to Ehlers and Clark (2000), this reliving process has three benefits. First, reliving
helps the individual to elaborate and integrate memories. Second, it provides opportunities to
examine and challenge cognitive appraisals of traumatic experiences. Third, reliving allows the
individual to examine and challenge catastrophic beliefs (e.g., that he or she will “lose control,”
“die,” “fall apart”) by recalling a trauma imaginally (Ehlers & Clark, 2000).
Treatment of PTSD
Meta-analyses and narrative literature reviews suggest that cognitive-behavioral
therapies, including exposure therapy, cognitive restructuring therapy, and stress inoculation
therapy, are efficacious treatments for PTSD (Bradley, Greene, Russ, Dutra, & Westen, 2005;
Davidson & Parker, 2001; Foa & Meadows, 1997; Shalev, Bonne, & Eth, 1996; Sherman, 1998).
Although evidence is limited and conflicting, research also has yielded some support for
psychodynamic and eye movement desensitization therapies as treatments for PTSD (Davidson
& Parker, 2001; Shalev, Bonne, & Eth, 1996).
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Exposure therapy, which has received the most attention in the research literature, is an
approach that encompasses a broad range of treatments, all of which require clients to confront
feared stimuli either imaginally or in vivo for varied durations and at varied intensity levels (Foa
& Meadows, 1997). Although research suggests that exposure therapy is an efficacious treatment
for PTSD (Bradley, Greene, Russ, Dutra, & Westen, 2005), concerns have been raised regarding
its use (Foa, Zoellner, Feeny, Hembree, & Alvarez-Conrad, 2002; Pitman et al., 1991; Tarrier et
al., 1999) because many clients find it to be aversive (Bradley, Greene, Russ, Dutra, & Westen,
2005). Indeed, there is some evidence that exposure therapy may cause a temporary increase in
PTSD symptoms, and thus may lead clients to leave treatment prematurely (Foa, Zoellner,
Feeny, Hembree, & Alvarez-Conrad, 2002). Further, the association between treatment dropout
and symptom exacerbation may be reciprocal; Tarrier and colleagues (1999) have posited that
missing exposure therapy sessions may further sensitize rather than desensitize an individual to
anxiety.
Concerns about elevated rates of treatment non-completion are based in part on findings
that up to 33% of individuals who enter exposure therapy in randomized controlled trials fail to
complete treatment (Devilly, Spence, & Rapee, 1998). Non-adherence rates are even higher (up
to 72%) in community clinical settings (Zayfert et al., 2005). It remains unclear, however,
whether individuals drop out of exposure-based therapies more often than they drop out of other
therapies for PTSD. Schnurr and colleagues (2007) found that among veterans with PTSD, the
treatment dropout rate was significantly higher in an exposure therapy condition than in a
present-centered treatment condition that focused on current life problems as a result of PTSD,
and that those who dropped out of treatment did so during imaginal exposure. In contrast, Foa
and colleagues (2002) found that sexual assault survivors whose symptoms were exacerbated
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during various types of treatment (prolonged exposure (PE) alone, PE and cognitive
restructuring, or waitlist) were not significantly more likely to drop out of treatment than women
whose symptoms did not get worse. However, it is unclear whether dropout rates differed across
treatment conditions.
Clearly there is both support for the use of exposure therapy in varied traumatized
populations and a need for caution in its application. Notably, some evidence suggests that
findings regarding efficacy may be less applicable to combat veterans, who tend to show less
pre- to post-treatment improvement in PTSD symptoms than individuals who have experienced
traumatic events unrelated to combat (Bradley et al., 2005). At this point, reasons for lower rates
of improvement among veterans are unclear, but could include higher rates of treatment nonadherence.
Treatment Non-Adherence in PTSD
In the psychotherapy and medical literatures, researchers refer to treatment nonadherence by different names, including dropout and attrition. I will use the terms non-adherence
and dropout interchangeably in the following review. Treatment non-adherence, or the failure to
complete prescribed medical and psychological regimens can lead to the worsening of
medical/psychological conditions, development of further health problems, need for additional
services, poorer work productivity, and decreases in quality of life (Christensen, 2004; Reis &
Brown, 1999). Despite these clear negative consequences, treatment non-adherence is common.
Studies in the medical literature yield estimates of 20 to 40% non-adherence to acute illness
regimens, 30 to 60% to chronic illness regimens, and up to 80% to preventative regimens
(Christensen, 2004). Adherence to treatments for psychological or psychiatric disorders is not as
extensively documented. However, studies suggest that rates of adherence to medical treatments
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for psychological disorders are moderate to low, that clients typically take 65% or less of
prescribed psychiatric medications than doctors recommend (Cramer & Rosenheck, 1998), and
that adherence rates tend to decline over time (Demyttenaere, 1997). Non-adherence to
psychotherapy also appears to be a widespread problem (Levensky & O'Donohue, 2006;
Ogrodniczuk, Joyce, & Piper, 2005), with premature treatment termination rates ranging from 30
to 75% for clients with varied disorders (Barrett, Chua, Crits-Christoph, Gibbons, & Thompson,
2008; Baekeland & Lundwall, 1975; Garfield, 1994; Smart & Gray, 1978; Wierzbicki & Pekarik,
1993). A contributing factor to the low adherence rates for psychotherapy may be the amount of
treatment necessary for clients to start to feel better; data suggest that the majority of clients
receiving psychotherapy both within the Veterans Health Administration and in other settings
tend to drop out before they have received an “adequate dose” for symptom relief (Barrett, Chua,
Crits-Cristoph, Gibbons, & Thompson, 2008; Cully, Henderson, Kunik, Tolpin, Jimenez, &
Petersen, 2008).
One barrier to drawing conclusions about adherence to psychological treatment is the
considerable variability in operational definitions of treatment adherence across studies.
Depending on the study, adherence has been defined as attending or coming on time to sessions
(Tarrier, Sommerfield, Pilgrim, & Faragher, 2000), beginning a recommended treatment (Rogers
& Bullman, 1995), completing homework (van Minnen & Hagenaars, 2002), taking medication
as prescribed (Shemesh et al., 2001), or sticking with versus dropping out of treatment after
enrollment (Kubiak, 2004; van Minnen, Arntz, & Keijsers, 2002). Each of these approaches has
strengths and weaknesses. Measuring treatment adherence using attendance records, for instance,
can be problematic if treatment is long-term and time-unlimited, which is historically common in
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psychotherapy especially as practiced in naturalistic settings (Hansen & Lambert, 2003; Pekarik,
1983).
Because definitions of adherence, as well as approaches to measuring the construct, vary
greatly, it has been difficult for researchers to isolate variables that reliably predict continued
engagement in psychotherapeutic treatment (Barrett et al., 2008; Baekeland & Lundwall, 1975;
Garfield, 1994; Hatchett & Park, 2003; Levensky, Fisher, & O'Donohue, 2006; Ogrodniczuk,
Joyce, & Piper, 2005; Pekarik, 1991; Wierzbicki & Pekarik, 1993). In the literature to date,
demographic variables have received the most attention as potential predictors. Indeed, the most
consistent finding in the literature is an inverse relationship between treatment dropout and
socioeconomic status (SES) (Baekeland & Lundwall, 1975; Berrigan & Garfield, 1981; Garfield,
1994; Wierzbicki & Pekarik, 1993). It is unclear, however, if low SES per se accounts for
increased dropout risk. An alternate possibility is that SES functions as a proxy for other
associated factors, such as minority racial status, low educational level, and being female, young,
and unmarried, each of which relates significantly to dropout rates both from psychotherapy
treatment in general (Wierzbicki & Pekarik, 1993) and from more focused treatment for chronic
depression (Arnow et al., 2007).
Client characteristics that extend beyond demographics also have been examined in
relation to treatment adherence for varying psychological disorders, but the findings regarding
such variables are mixed across studies (Baekeland & Lundwall, 1975). Several studies
demonstrate associations between non-adherence and pre-treatment symptom severity or
comorbidity status. Persons and colleagues (1988), for example, found a negative association
between pre-treatment depression scores and adherence to psychotherapy in depressed clients
who received cognitive therapy in a private practice setting. Further, clients with comorbid
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personality disorders were more likely to drop out of treatment than were those without
personality pathology (Persons, Burns, & Perloff, 1988). In another study, chronically depressed
outpatients receiving cognitive behavioral therapy and/or medication were at higher risk for nonadherence if they had comorbid anxiety disorders (Arnow et al., 2007). Finally, studies of
treatment for alcoholism suggest positive associations between treatment dropout and such
factors as social isolation, poor motivation for treatment, and nonabstinence (Baekeland &
Lundwall, 1975; Cummings, 1977; Smart & Gray, 1978).
Beyond demographics and client characteristics, some researchers have followed
Wierzbicki and Pekarik’s (1993) suggestion that more psychologically complex variables, such
as client expectations of treatment, merit consideration as predictors of adherence. Research
utilizing this approach is still unusual, but yields interesting findings. For example, expectations
about treatment duration better predicted number of therapy sessions attended than did
demographic variables, with the exception of age (Garfield, 1994; Mueller & Pekarik, 2000;
Pekarik, 1991). Together, these disparate areas of research suggest that multiple factors may
influence adherence to treatment regimens.
Relatively little is known about factors that may affect adherence specifically in those
with PTSD, particularly adherence to exposure therapy, a treatment of choice for the disorder.
This is surprising, given that existing studies examining treatment adherence in individuals with
PTSD consistently show that adherent clients tend to have better outcomes, including decreased
PTSD symptoms (Matthieu & Ivanoff, 2006; Schnurr et al., 2003; Scott & Stradling, 1997;
Tarrier, Sommerfield, Pilgrim, & Faragher, 2000; van Minnen & Hagenaars, 2002; Vermeire,
Hearnshaw, Van Royen, & Denekens, 2001). Tarrier and colleagues (2000), for example, found
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that the best predictor of poor treatment outcome (PTSD severity) in a mixed-trauma population
was inconsistent attendance to cognitive behavioral therapy sessions.
The lack of available information about predictors of adherence to PTSD treatment
appears to reflect several issues. First, most research on adherence to psychotherapy among
individuals with PTSD is embedded in the context of treatment outcome studies. For example,
none of the PTSD treatment studies reviewed in a recent meta-analysis examining the efficacy
and generalizability of controlled trials of psychotherapy treatments for PTSD (Bradley et al.,
2005) were designed explicitly to examine treatment adherence. Instead, treatment adherence
served, at best, as a secondary variable that might hold some relevance to treatment outcome. In
fact, 32% of the published studies that reported completion or dropout rates did not examine or
report differences between dropouts and completers. This lack of data regarding adherence is
particularly striking for studies of veterans. Forty percent of the reviewed studies that focused on
veterans either did not examine or did not report differences between dropouts and completers
(Bradley, Greene, Russ, Dutra, & Westen, 2005).
Second, rates of adherence to treatment in clients with PTSD vary, in part, depending on
the setting, the types of treatment, and patient populations or diagnostic groups under study (Foa
et al., 2005; Hembree et al., 2003; McDonagh et al., 2005). Active treatments tend, for example,
to have higher dropout rates than control treatments (Foa et al., 2005), and adherence appears to
be lower in clinical settings than in randomized, controlled trials, where participants are
stringently selected and monitored (Bradley et al., 2005; Burstein, 1986; Fisher et al., 1993;
Zayfert et al., 2005). This makes it difficult to generalize findings about predictors from one
study to another or to compare results across studies.
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Third, studies of treatment adherence in PTSD differ dramatically in their definitions of
treatment dropout. Many studies provide no information except the number of individuals who
dropped out of treatment for any reason (e.g., Bryant, Moulds, Guthrie, Dang, & Nixon, 2003).
Some studies deem treatment completed when the therapist and client agree that they have
achieved PTSD treatment goals (Zayfert et al., 2005). Others define dropout based on the
number of sessions clients attended (e.g., Glynn et al., 1999). These different definitions make it
difficult to draw conclusions about adherence to psychotherapy across studies (Barrett et al.,
2008).
Fourth, studies also differ in their selected predictors of adherent behaviors (Bradley,
Greene, Russ, Dutra, & Westen, 2005; Bryant et al., 2007; Burstein, 1986; Fisher, Winne, &
Ley, 1993). Bradley and colleagues (2005) found that in studies that provided adequate data to
permit examination of adherence predictors, no one set of variables consistently predicted
treatment completion or treatment dropout (see Appendix A). A similar review of broadly
defined mental health service use among trauma survivors found comparable inconsistencies in
predictors of service use (Elhai, North, & Frueh, 2005).
Of the studies reviewed in the Bradley et al. (2005) meta-analysis, some found that
treatment dropouts differed from completers on demographic characteristics (Foa et al., 1999;
Foa, Rothbaum, Riggs, & Murdock, 1991; Krakow et al., 2001; Paunovic & Ost, 2001; Schnurr
et al., 2003). Other controlled trials found significant differences between treatment completers
and dropouts on measures of non-PTSD psychopathology (e.g., depression, anxiety), with
dropouts showing more severe symptoms than completers (Bryant, Moulds, Guthrie, Dang, &
Nixon, 2003; Schnurr et al., 2003). Finally, some studies found that treatment dropouts had more
severe overall PTSD symptoms than did treatment completers (Marks, Lovell, Noshirvani,
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Livanou, & Thrasher, 1998; Zlotnick et al., 1997) or more severe PTSD avoidance/emotional
numbing symptoms (Bryant, Moulds, Guthrie, Dang, & Nixon, 2003; Glynn et al., 1999). Other
studies, in contrast, failed to find differences between completers and non-completers on
demographic characteristics (Brom, Kleber, & Defares, 1989; Bryant, Moulds, Guthrie, Dang, &
Nixon, 2003; Cloitre, Koenen, Cohen, & Han, 2002; Tarrier et al., 1999; Taylor et al., 2003),
measures of non-PTSD symptoms (Cloitre, Koenen, Cohen, & Han, 2002; Foa et al., 1999;
Resick, Nishith, Weaver, Astin, & Feuer, 2002; Tarrier et al., 1999; Taylor, 2003), measures of
overall PTSD symptoms (Cloitre, Koenen, Cohen, & Han, 2002; Krakow et al., 2001; Resick,
Nishith, Weaver, Astin, & Feuer, 2002; Schnurr et al., 2003; Tarrier et al., 1999; Taylor, 2003)
or measures of PTSD-avoidance (Tarrier et al., 1999; Taylor, 2003).
Results from several controlled trials of PTSD therapy and adherence did not become
available until after Bradley and colleagues published their meta-analysis in 2005 (see Appendix
B). Consistent with results of the meta-analysis, these studies also failed to find reliable
predictors of treatment completion or dropout. Findings in these studies regarding demographic
characteristics (e.g., age) are conflicting, with some evidence suggesting that they relate to
treatment dropout (Foa et al., 2005; Kubany et al., 2004; Matthieu & Ivanoff, 2006; Resick,
Galovski, Uhlmansiek, Scher, Clum, & Young-Xu, 2008) and other evidence indicating that they
do not (Power et al., 2002). Similarly, associations between treatment adherence and both
severity of global psychopathology (Kubany et al., 2004; McDonagh et al., 2005; Taylor et al.,
2001) and severity of PTSD symptoms (Matthieu & Ivanoff, 2006; Taylor et al., 2001) vary
across studies. Lastly, one study found that the only difference between treatment completers and
dropouts was more severe PTSD-avoidance/emotional numbing symptoms in dropouts (Power et
al., 2002).
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Studies that base predictions about adherence to exposure therapy on theoretical models
in accordance with the recommendations of Christensen (2004), Vermeire and colleagues (2001),
and Andersen (1995) are rare, but have yielded interesting findings. Researchers have started to
use the behavioral model of service utilization (Andersen, 1995) to examine what predicts
general mental health use in veterans with PTSD (Sayer, Clothier, Spoont, & Nelson, 2007).
Sayer and colleagues (2007) found, in a sample of veterans with PTSD who were submitting a
claim to become financially compensated for PTSD, that mental health use was facilitated by
younger age, marriage, and dependence on public insurance. Spoont and colleagues (2005)
examined, in a study based on the Self Regulation Model (Leventhal, Diefenbach, & Leventhal,
1992), whether health beliefs predicted adherence to psychotherapy in combat veterans
undergoing treatment for PTSD. They found that veterans who believed in psychosocial rather
than biological explanations for PTSD or who reported stronger beliefs that PTSD had
negatively affected their lives were more likely to participate in psychotherapy.
Similarly, Bryant and colleagues (2007) based their investigation of associations between
avoidance and exposure treatment adherence on Ehlers’ and Clark’s (2000) cognitive model of
PTSD. These researchers proposed that individuals who dropped out of treatment would be those
who entered treatment with maladaptive coping strategies that interfered with treatment
completion (Bryant et al., 2007). More specifically, they hypothesized that individuals with
PTSD who were more avoidant would be more likely to drop out of treatment. In fact, their
findings demonstrated that individuals with PTSD related to motor vehicle accidents or nonsexual assaults who dropped out of treatment had significantly higher avoidance scores than
individuals who completed treatment. Bryant and colleagues (2007) concluded that individuals
who have a proclivity to avoid aversive events avoid therapy by dropping out of treatment.
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Although treatment adherence rates are low in many traumatized populations, some
evidence suggests that veterans have particular difficulty entering and adhering to treatment.
Nearly 40% of Vietnam Veterans who developed PTSD, for example, have never sought mental
health treatment (Kulka et al., 1990). Further, those who have completed treatment show smaller
treatment gains than do individuals with PTSD due to other traumatic experiences (Bradley,
Greene, Russ, Dutra, & Westen, 2005). Some evidence suggests that this could reflect, at least in
part, poor adherence: veterans with PTSD miss more therapy appointments than veterans in other
diagnostic groups such as clients with schizophrenia, schizoaffective disorder, bipolar disorder,
major depressive disorder, and dysthymic disorder (Sparr, Moffitt, & Ward, 1993).
Combat veterans with PTSD differ in other notable ways from individuals who have
experienced non-combat-related trauma, which may influence their risk for non-adherence (Foa
& Meadows, 1997). First, secondary gains from remaining ill, such as disability compensation
for physical, medical, or psychological conditions that relate back to military service, may be
greater for veterans, especially those treated in the VA system, than for non-veteran trauma
survivors. For example, veterans with PTSD can receive monetary compensation for a PTSD
diagnosis due to a trauma during military service (a service-connected condition). Those who
receive treatment that improves their PTSD symptoms may risk a decrease in this compensation
(Frueh et al., 2003).
Second, traumatized veterans are unusual in that they are often both perpetrators and
victims of trauma. This dual and conflicting set of roles may elicit feelings of guilt and shame
that are more rational than those experienced by other groups, such as rape survivors (Foa &
Meadows, 1997). Third, combat veterans often experience severe anger in addition to classic
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PTSD symptoms, which interferes with the therapeutic alliance and with treatment adherence
(Chemtob, Novaco, Hamada, & Gross, 1997; Stevenson & Chemtob, 2000).
Non-adherence rates from early PTSD treatment outcome studies conducted with
veterans range from zero (Keane, Fairbank, Caddell, & Zimering, 1989) to 33% (Devilly,
Spence, & Rapee, 1998), and less tightly controlled treatment outcome studies report a slightly
wider range (Chemtob, Novaco, Hamada, & Gross, 1997). Until recently, however, studies of
PTSD treatment occurred primarily in inpatient units of veterans’ hospitals where participants
would have had difficulty refusing treatment (Boudewyns & Hyer, 1990; Hyer, Woods, Bruno,
& Boudewyns, 1989; Silver, Brooks, & Obenchain, 1995). Additionally, many early treatment
outcome studies, which typically used some form of exposure therapy, either did not report
adherence rates or did not report whether and how dropouts and completers differed (Carlson,
Chemtob, Rusnak, Hedlund, & Muraoka, 1998; Devilly, Spence, & Rapee, 1998; Frueh, Turner,
Beidel, & Mirabella, 1996; Hyer, Woods, Bruno, & Boudewyns, 1989; Pitman, Orr, Altman, &
Longpre, 1996; Silver, Brooks, & Obenchain, 1995).
Findings from more recent studies of PTSD treatment adherence in veterans are
consistent with earlier research, in that dropout rates are relatively high, particularly for active
treatments, and predictors of adherence are mixed (Kutter, Wolf, & McKeever, 2004; Monson et
al., 2006; Schnurr et al., 2007; Schnurr et al., 2003). Some studies found that demographic
characteristics, quality of life, or family problems differentiated treatment completers from
dropouts (Creamer, Elliott, Forbes, Biddle, & Hawthorne, 2006; Schnurr et al., 2003), but others
did not (Chemtob, Novaco, Hamada, & Gross, 1997; Cooper & Clum, 1989; Kutter, Wolf, &
McKeever, 2004; Munley, Bains, Frazee, & Schwartz, 1994). Creamer and colleagues (2006),
for example, found that younger, unmarried Vietnam Veterans dropped out of group-based
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treatment provided in varied settings (inpatient, outpatient, and day programs) more often than
older, married Vietnam Veterans. Mixed results have been found regarding differences between
treatment completers and dropouts in severity of PTSD symptoms (Chemtob, Novaco, Hamada,
& Gross, 1997; Kutter, Wolf, & McKeever, 2004; Munley, Bains, Frazee, & Schwartz, 1994;
Schnurr et al., 2003), PTSD-avoidance/emotional numbing symptoms (Creamer, Elliott, Forbes,
Biddle, & Hawthorne, 2006; Glynn et al., 1999; Kutter, Wolf, & McKeever, 2004),
psychopathology (e.g., depression, anxiety, substance use)(Chemtob, Novaco, Hamada, & Gross,
1997; Cooper & Clum, 1989; Creamer, Elliott, Forbes, Biddle, & Hawthorne, 2006; Kutter,
Wolf, & McKeever, 2004; Munley, Bains, Frazee, & Schwartz, 1994; Schnurr et al., 2003; Sparr,
Moffitt, & Ward, 1993), and feelings of anger, guilt and shame (Chemtob, Novaco, Hamada, &
Gross, 1997; Kutter, Wolf, & McKeever, 2004).
Although the relevant body of research is growing, several factors limit current
understanding of what predicts adherence to treatment in veterans with PTSD. First, most studies
focus on predictors of treatment outcome rather than treatment adherence, which tends to be
examined only in secondary analyses. Second, most studies report treatment dropout rates
instead of rates of adherence, with the notable exception of a study conducted by Schnurr and
colleagues (2003). These researchers conducted a randomized, clinical trial of trauma-focused
group therapy for Vietnam Veterans. They found that participants who attended at least 80% of
trauma-focused treatment achieved a significant improvement in avoidance, numbing, and PTSD
symptoms compared to those who completed present-centered treatment. Finally, with the
exception of one study (Spoont et al., 2005), researchers have not selected predictors of
adherence among veterans based on theoretical models. I designed the present study as a first
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step toward addressing these limitations, with a narrow focus on veterans of the Iraq and
Afghanistan Wars (Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF)).
The veterans of the OEF/OIF campaigns are largely male, under the age of thirty,
working, and Caucasian; additionally, half are married (Fontana & Rosenheck, 2008; Hoge,
Auchterlonie, & Milliken, 2006; Seal, Bertenthal, Miner, Sen, & Marmar, 2007). Despite
demographic similarities to veterans of 20th century wars, this group constitutes an unusual
population of combat veterans in several ways. Not only do these soldiers face multiple tours of
duty, unlike veterans of other recent conflicts, but they are also more likely to survive severe
injuries than were veterans of past conflicts (Hoge et al., 2004). These factors likely increase
their risk for PTSD, which is common in this population (Seal, Bertenthal, Miner, Sen, &
Marmar, 2007). Further, unlike veterans of the Vietnam War, many of whom did not present for
mental health treatment until many years after combat, a growing number is seeking assistance
shortly after returning from combat zones. Indeed, three times more OEF and OIF veterans than
Vietnam Veterans have enrolled in the VA health care system (Seal, Bertenthal, Miner, Sen, &
Marmar, 2007).
Given the unusual characteristics of OEF/OEF veterans, predictors of treatment
adherence for this population may differ from those for veterans of earlier conflicts (e.g.,
Vietnam War; Spoont, Sayer, & Nelson, 2005). Only recently, however, have researchers begun
to examine treatment responses and correlates in this population. In one of the only published
treatment outcome studies to date that includes participants from this population, along with
veterans of earlier conflicts, female veterans with primarily sexual traumas were treated with
either prolonged exposure therapy or with present-centered therapy (Schnurr et al, 2007).
Treatment dropout rates and numbers of missed sessions were significantly higher in the
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prolonged exposure than in the present-centered therapy. No data regarding correlates of
treatment dropout, however, were presented. Another preliminary investigation of virtual reality
therapy for this population was piloted with active-duty service members (Rizzo, Reger, Gahm,
Difede, & Rothbaum, 2009). Results were promising and indicated a significant decrease in
PTSD and depression scores post-treatment. This study reported 20 service members completed
the treatment, and 13 dropped out. The average number of completed sessions was less than 11.
This study did not report examine or report differences between completers or dropouts.
Avoidance as a Predictor of Non-Adherence
Research on adherence to psychotherapy in clients with PTSD has examined many
individual predictors in different samples and yielded mixed findings. What has clearly emerged
is the need for theory to drive the selection of variables to test as predictors of adherence to
psychotherapy. Ehlers’ and Clark’s (2000) cognitive model of PTSD and Foa and Kozak’s
(1986) information processing model of PTSD, taken together, serve as a theoretical framework
for the current study. These models postulate that avoidance constitutes a major obstacle to
changes in an individual’s negative appraisals and memories of traumatic events, and thus also
prevents successful engagement in and completion of treatment. Although ten studies have
examined this association in different traumatized populations, yielding largely positive findings,
none have focused on veterans who recently returned from combat and whose symptoms are thus
more likely to be focused explicitly on their combat experiences. I therefore chose to examine
avoidance/emotional numbing symptoms as a predictor of non-adherence to psychotherapy in
OEF/OIF veterans.
Avoidance is particularly interesting as a predictor of OEF/OIF veterans’ adherence to
PTSD treatment because the efficacious treatments available for PTSD typically include
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exposure therapy (Bradley, Greene, Russ, Dutra, & Westen, 2005), which requires clients to
discard avoidant coping strategies. This may be particularly hard for individuals who are more
avoidant to begin with; high levels of avoidance of stimuli that are associated with or that trigger
the memory of a trauma may lead individuals to be less tolerant of treatment approaches (e.g.,
exposure therapy) that involve confronting a traumatic memory (Power et al., 2002).
Studies of samples with non-combat-related PTSD have yielded largely, but not
uniformly, positive findings regarding the relationship between avoidance and treatment dropout,
regardless of the type of trauma or the measure of avoidance used (Brady, Dansky, Back, Foa, &
Carroll, 2001; Bryant, Moulds, Guthrie, Dang, & Nixon, 2003; Bryant et al., 2007; Burstein,
1986; Power et al., 2002). Two studies, however, found no significant relationship between
avoidance and dropout (Tarrier et al., 1999; Taylor et al., 2001). Notably, most of these studies
examined treatment adherence secondary to a focus on treatment outcomes (Brady, Dansky,
Back, Foa, & Carroll, 2001; Bryant, Moulds, Guthrie, Dang, & Nixon, 2003; Power et al., 2002;
Tarrier et al., 1999; Taylor et al., 2001).
Of the studies that have examined the role of avoidance in adherence to PTSD treatment,
only three have focused on veterans, most of whom were traumatized during the Vietnam War
and sought treatment years after they returned from combat (Creamer, Elliott, Forbes, Biddle, &
Hawthorne, 2006; Glynn et al., 1999; Kutter, Wolf, & McKeever, 2004). Nonetheless, these
studies yielded conflicting findings, perhaps in part because of differences in the types of
treatment offered (e.g., exposure, psychoeducational, individual, or group therapy), differences
in definitions of treatment dropouts (e.g., stating that clients dropped out of treatment at some
point and defining completion such that almost every client completed treatment), and
complexities of mental health issues in individuals seeking treatment years after they were
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initially traumatized. One way to address these conflicting findings is to examine associations
between avoidance and adherence to psychotherapy in a population of veterans with PTSD who
recently returned from combat and whose presentations are thus not complicated by long
intervals between their combat tours and their initial presentation for treatment.
Overview of Study
I designed this study as a first step toward addressing several limitations of the adherence
literature. First, I examined adherence in a circumscribed, clearly defined subset of veterans with
PTSD. Second, I examined potential predictors of adherence to psychotherapy that I selected
based on theoretical models of the development and maintenance of PTSD. Third, I clearly
defined adherence as the percentage of scheduled psychotherapy sessions a veteran attended.
Given the theoretical (Ehlers & Clark, 2000; Foa & Kozak, 1986) and empirical support
(e.g., Brady, Dansky, Back, Foa, & Carroll, 2001; Bryant et al., 2007;) for a negative association
between severity of avoidance/emotional numbing symptoms and psychotherapy adherence, I
predicted that there would be a significant, negative association between severity of
avoidance/emotional numbing symptoms and psychotherapy adherence. Moreover, I predicted
that this negative association would remain significant after I statistically controlled for
demographic and clinical variables that have been examined as predictors of adherence in
previous studies or that were significantly associated with the outcome variable.
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CHAPTER 2.
METHODS
This study used an archival dataset developed with the approval of the Emory and
Georgia State Universities and Veterans Administration Institutional Review Boards for the
purpose of evaluating the Trauma Recovery Program (TRP) at the PTSD specialty clinic at the
Atlanta Veterans Administration Medical Center. This dataset includes participants’ responses
on a standard set of self-report measures [Veteran Affairs Military Stress Treatment Assessment
(VAMSTA; Fontana, Ruzek, McFall, & Rosenheck, 2006)] completed at initial intake into the
TRP and a detailed intake interview conducted by a licensed or supervised mental health
professional to evaluate symptoms of PTSD, depression, substance use, suicidality, and
childhood family, social, and learning history. Additionally, veterans and their clinicians
provided data at multiple time points after intake regarding the veteran’s symptoms, treatment
adherence, and type of treatment received from the TRP. The primary outcome measures of
interest include PTSD symptoms, treatment adherence, symptoms of psychopathology, and
emotional functioning. Secondary outcome measures include measures of quality of life and
aspects of life history.
Participants
Participants (N=160 in the final sample) represent all consecutive referrals to the TRP
between July 2006 and May 2008 with the exception of any clients who declined to complete
program evaluation data. The number of veterans who refused to complete the program
evaluation data is unknown. Only veterans of the Operation Enduring Freedom (OEF) campaign
in Afghanistan or the Operation Iraqi Freedom (OIF) campaign were included in the present
study.

23
Of the 252 OEF/OIF veterans whose data were initially coded and entered, 25 were
referred out of the TRP, 18 never returned for treatment post-intake, and 31 only received
medication management (See Tables 1 and 2 for descriptive data regarding included and
excluded participants). These 74 veterans were thus excluded from the dataset. Furthermore, 7
veterans were excluded because their total PTSD Checklist-Military version (PCL-M; Weathers
et al., 1993) scores were below the recommended total cutoff score (34) for a probable diagnosis
of PTSD (Bliese, Wright, Adler, Cabrera, Castro, & Hoge 2008). Eleven veterans were excluded
from the dataset due to having data with outlier scores on more than one variable. Final analyses
included only the 160 veterans who received psychotherapy.
Table 1: Veterans who were referred out of the TRP
Referred Out
Distance/closer to home
No PTSD
Psychotic
Conflicts with work
No combat trauma or MST
No need for therapy/ medications
Unclear why
Total

Frequency
6
8
4
2
1
1
3
25

Table 2: Veterans who never returned for treatment post-intake
Never Returned
Frequency
Unclear why
11
Did not want treatment
4
Went elsewhere for treatment
1
Childcare issues
1
Being redeployed
1
Total
18

Percent
2.5
3.3
1.7
0.8
0.4
0.4
1.2
10.4

Percent
4.6
1.7
0.4
0.4
0.4
7.5

Cramer’s V tests and analyses of variance (ANOVA) were used to determine if veterans
who received psychotherapy and were thus included in the final sample differed from those who
were excluded because they either received medication management alone (medication group) or
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did not return to the TRP for treatment (no-TRP-treatment group) (see Appendix D for detailed
results). Comorbid diagnoses were more common in the no-TRP-treatment group than in the
other two groups (Cramer’s V = 0.17, p= 0.04). Groups also differed according to trauma
exposure (p=.000), overall PCL score at admission (p=.01), total depression score (p=.01), and
PCL re-experiencing score (p=.03), with the no-TRP-treatment group obtaining consistently
lower scores than the therapy group and, in some cases, the medication management group. No
significant differences among groups were evident on any other demographic or clinical
variables (all p’s > .05).
Full demographic and clinical data for the final sample are presented in Table 3. Veterans
in this sample (N=160) were largely male (N=135; 84%), of a minority race or ethnicity (N=103;
64%), and were currently married (N=84; 53%). The majority had enlisted in the military (only
four were officers) and most were in either the Army (78%) or the Marines (12%). Participants’
ranks ranged from Private First Class to Sergeant Major. The majority of veterans in the sample
(N=155; 96%) reported experiencing multiple traumatic stressors during deployment to Iraq or
Afghanistan. The most frequently endorsed stressors included going on combat patrols or
missions, encountering explosive devices, receiving hostile fire, witnessing injury or death,
exposure to the sight, sound, or smell of dying people, and knowing someone who was seriously
wounded or killed. A small minority (N=11; 7%) reported experiencing a military sexual trauma.
Most veterans in the sample had at least one comorbid diagnosis (N=106; 66%), most
commonly depression (43%), substance abuse or dependence (18%), and/or anxiety (12%).
Some veterans reported having suicidal (N=25; 15%) and/or homicidal (N=11; 7%) thoughts.
The majority had received previous mental health treatment (68%) and/or had been on
medication for a mental health issue (73%); 18% had been psychiatrically hospitalized. Non-
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Table 3: Demographics for N=160 veterans
Measured variable
Overall Demographics
Age
Education level
Days of employment
Birth order
Gender
Male
Female
Race/Ethnicity
White
African-American, not Hispanic
Hispanic, not White
Hispanic, African-American
Asian
Other
Marital Status
Married
Unmarried
Childhood Variables
Child abuse
Stable family
Discipline problems
Psychological Variables
Comorbid issues
Depression
Quality of life
Trauma exposure
Alcohol abuse
Drug abuse
Violence & Anger
Medical Issues
Number medical problems
Pain scale
Compensation Variables
Service connection
PTSD connection
Perceptions
Expected ease of treatment
Predictor Variables
PCL Re-experiencing
PCL Avoidance & Emotional Numbing
PCL Hyperarousal
PCL Avoidance Only
PCL Emotional Numbing only
Type of treatment
Exposure therapy
Time-limited treatment
Adherence variables
Sessions scheduled
Sessions attended
Non-exposure therapy adherence
Time-limited adherence
Unlimited therapy adherence
Therapy completion
Overall psychotherapy
Exposure therapy
Non-exposure therapy
Time-limited therapy
Unlimited therapy

Mean (SD)
33.05 (8.26)
13.43 (1.62)
11.85 (11.02)
2.19 (1.52)

0.96 (0.85)
24.74 (6.27)
34.29 (9.55)
9.86 (4.04)

Range

Percent

(20-57)
(11-17)
(0-30)
(0-6+)
135
25

84.37
15.63

57
89
7
3
2
2

35.63
55.63
4.38
1.88
1.25
1.25

84
75

52.83
47.17

56
104
32

37.84
75.91
22.07

44
7
140

27.85
4.38
87.50

73
111

45.63
69.38

42
28
20
32
10

26.25
38.36
18.02
28.83
20.41

(0-3+)
(10.48-36)
(12-60)
(1-16)

1.24 (1.01)
5.83 (2.04)

(0-3+)
(0-10)

26.62 (31.54)
6.99 (14.87)

(0-100)
(0-70)

2.23 (0.67)

(0.87-4)

17.92 (4.58)
24.45 (5.98)
20.57 (3.54)
7.42 (2.01)
11.57 (2.99)

(6-25)
(9-35)
(11-25)
(2-10)
(4-15)

10.62 (5.83)
6.41 (4.78)
.53 (.35)
.54 (.33)
.65 (.32)

N

(1-39)
(0-19)
(0-1)
(0-1)
(0-1)
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psychiatric medical problems were common; 75% of veterans reported at least one medical
problem and 76% reported receiving current medical treatment. Nearly half of the veterans
(N=74; 46%) in this sample reported a history of a traumatic brain injury (TBI), and 69 indicated
that the TBI had occurred during their military service.
Some participating veterans reported having experienced notable difficulties during their
youth. Approximately a fifth of the sample (20%), for example, reported childhood discipline
problems that included getting suspended or expelled from school, (48%), fighting (39%),
truancy (26%), breaking the law (26%), getting into trouble frequently (13%), and running away
from home (10%). Childhood maltreatment appeared relatively common; 56 veterans (35%)
endorsed having experiencing physical (N=33), sexual (N=25), and/or emotional (N=30) abuse.
Procedure
All participants were referred to the TRP by health care providers within the Veterans
Administration Medical Center (VAMC) system, and all completed an initial questionnaire and
intake interview (Figure 2).
Referral to TRP

Initial Evaluation: VAMSTA & Intake
Interview (N=252)

Refer out: N=18
Never returned post-intake: N=25

Assigned to treatment: Individual
(N=68), Group (N=109), Medication
(N=143)

Figure 2: Client flow in the Trauma Recovery Program
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After intake, the TRP team discussed each veteran’s psychological symptoms and diagnoses and
determined appropriate treatment. Veterans were referred out of the TRP if they had a current
psychotic disorder, substance dependence, or were in imminent danger of hurting themselves or
someone else. Veterans identified as appropriate for the TRP were assigned to a treatment based
on the initial intake, the patient’s availability for treatment, the treatments currently available,
and the treatment team’s impression of which treatment would be most beneficial. OEF/OIF
veterans were assigned to either exposure-based (individual or group) or non-exposure based
treatments (e.g., individual nonspecified therapy, psychoeducational group, post-military readjustment group). The psychoeducational groups focused on teaching veterans about the
symptoms of PTSD and coping with the disorder. This group met weekly for either four or eight
weeks and included veterans of different combat theaters. The eight-week psychoeducational
group included both veterans and their family members. The post-military re-adjustment group
was an ongoing weekly group in which participants primarily discussed issues related to
adjusting after military services; however, group members were also free to raise other issues.
The exposure therapy groups were time-limited (13 or 16 weeks). The 13-week group met
weekly, with a focus on interoceptive group exposure and individual exposure exercises. This
group included only OEF/OIF veterans. The 16-week group met twice a week; treatment
consisted of three phases: building group cohesion, exposure work, relapse prevention, and
“closing the wound,” which involved a funeral for fallen soldiers and forgiving oneself or others.
This group included veterans of various combat theaters, but the majority had served in the
Vietnam War. All veterans were also assigned to a psychiatrist who managed their medication
regimens while they were in psychotherapy, but for unknown reasons, 17 veterans never met
with their assigned psychiatrists. Lastly, some veterans (N=16) completed a non-exposure based
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treatment prior to entering exposure-based treatment to ensure that they received some therapy
while waiting for placement in an exposure-based group.
Measures
Veteran Affairs Military Stress Treatment Assessment (VAMSTA; Fontana, Ruzek,
McFall, & Rosenheck, 2006). This self-report instrument, which is typically completed at
numerous time points during the first four months of treatment at the VAMC, combines
demographic questions (e.g., marital status and days employed) and multiple well-validated
measures into one questionnaire assessing symptom severity, social functioning, quality of life,
and service use (Fontana & Rosenheck, 1996; Fontana, Rosenheck, Ruzek, & McFall, 2006).
The VAMSTA demonstrates high stability at both the item and scale levels, as well as high
homogeneity of items within subscales and indices (Fontana, Ruzek, McFall, & Rosenheck,
2006). The VAMSTA is psychometrically sound and is recommended for routine monitoring of
veterans’ clinical status and treatment outcomes. Five measures from the VAMSTA—the
Quality of Life, Depression, Alcohol and Substance Use scales; Violence and Anger scale, and
the PTSD Checklist (PCL-M)—were used in the present study.
VAMSTA Depression (see Appendix E). This is a self-report measure, derived from the
Patient Health Questionnaire (PHQ; Spitzer, Kroenke, & Williams, 1999) which measures
depressive symptoms over the previous two weeks. This measure demonstrates high internal
consistency (alphas range from .88 to .90 based on two waves of data collection). Total score on
this measure served as a covariate in regression analyses. The internal consistency of this
measure in the current sample of veterans was high (α = .87).
VAMSTA Alcohol and Drug Use (see Appendix F). These self-report measures ask about
how often alcohol and drugs have disrupted aspects of one’s life in the past four months. Fontana
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and colleagues (2006) found the internal consistency of the questions about alcohol use to be
good (alphas ranged from.81 to .93 in two waves of data collection). They found evidence of
similarly high internal consistency for the questions about drug use (α = .96). The alcohol use
measure is derived from the Drinker Inventory of Consequences (Forcehimes, Tonigan, Miller,
A., & Baer, 2007). These variables were dichotomized in the present study due to skewness and
kurtosis and were used as covariates in the analyses.
VAMSTA Quality of Life (see Appendix G). This self-report measure is derived from the
Quality of Life Interview (Lehman, 1988), which asks about people’s feelings about different
aspects of their life (e.g., friends, family, finances, health, etc). This scale demonstrates a testretest reliability of .80, and an internal consistency of .81-.90 based on two waves of data
collection (Fontana et al., 2006). The internal consistency of this measure in the present sample
was high (α = .88). Total score on this measure served as a covariate in analyses.
VAMSTA Violence and Anger Scale (see Appendix H; Violence Inventory; Kulka,
Schlenger, Fairbank, Hough, Jordan, Marmar, & Weiss, 1990). This is an 8-item self-report
measure of the presence of conflict with others. Veterans indicate if they have engaged in any of
a list of conflictual behaviors (i.e., destroyed property, threatened someone with physical
violence, had a physical fight with someone, threatened someone with a weapon, used a weapon
against someone, had thoughts of hurting someone, were verbally abusive, or broke off contact
with someone out of anger or fear of losing control) in the past 4 months. This scale
demonstrates a test-retest reliability of .86, and an internal consistency of .67-.72 based on two
waves of data collection (Fontana et al., 2006). The dichotomized variable (i.e., presence of
violence versus a denial of violence) was used as a covariate in the present analyses.
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VAMSTA PTSD Checklist (PCL; see Appendix I; Weathers, Litz, Herman, Huska, &
Keane, 1993). This is a 17-item self-report measure of the presence and severity of PTSD
symptoms participants were “bothered by…in the past month.” Participants rated their levels of
distress for each symptom on a 5-point scale that ranges from 1 (“not at all”) to 5 (“extremely”).
There are several versions of the PCL; the original was the PCL-M (military), which was used in
the present study and which asks about problems associated with "stressful military
experiences." The original validation sample included 123 Vietnam Veterans, but this measure
has subsequently been validated and used in other populations as well (Blanchard, JonesAlexander, Buckley, & Forneris, 1996; Cook et al., 2005; Lang, Laffaye, Satz, Dresselhaus, &
Stein, 2003).
The PCL can be scored in several ways. A total score (range 17-85) can be obtained by
summing the scores on all 17 items. A cutoff score of 34 is used to indicate likely presence of a
PTSD diagnosis in this veteran population (Bliese et al., 2008). A second way to score the PCL
is to examine responses to determine if the respondent meets the PTSD diagnostic criteria
specified in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV;
APA, 2000) and to combine this information with the total score to determine PTSD status
(Norris, Hamblen, Wilson, & Keane, 2004). Separate scores can also be calculated for Criteria B
(re-experiencing symptoms), C (avoidance/emotional numbing), and D (hyperarousal). Total
scores for the three criteria (re-experiencing, avoidance/emotional numbing, and hyperarousal)
were used in the present study as covariates and independent variables.
The psychometric properties of the PCL-M include a test-retest reliability of .96 across a
few days, high overall internal consistency (α = .97), and internal consistency estimates ranging
from .92-.93 for the subscales. Alpha for this measure in the present sample of veterans was .93.
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The re-experiencing scale had an alpha of .91, the avoidance and emotional numbing symptom
cluster had an alpha of .85, and the hyperarousal symptoms had an alpha of .81. The PCL-M has
a .93 correlation with the Mississippi Scale for Combat-Related PTSD (Keane, Caddell, &
Taylor, 1988). Results have been found to be consistent with PTSD diagnoses obtained using the
Structured Clinical Interview for DSM-III-R (SCID; Spitzer, Williams, Gibbon, & First, 1990),
which is one of the “gold standard” instruments for diagnosing PTSD. Schnurr and colleagues
(2007) and Monson and colleagues (2006) found similar agreement between PCL-M scores and
diagnoses obtained using the Clinician Administered PTSD Scale (CAPS; Weathers, Keane, &
Davidson, 2001), another “gold standard” of PTSD assessment.
The PCL-M avoidance and emotional numbing total score is the primary independent
variable of interest in this study. I also broke this total score into its subcomponents of the two
avoidance symptoms (α = .82) and the emotional numbing symptoms (.84) because there is some
evidence that the total symptom score may not be measuring a unitary symptom cluster (e.g.,
Litz, 1992), and these variables were used as exploratory independent variables. The avoidance
score consisted of the total score on the two items that explicitly focused on avoidance (avoiding
thinking about or talking about a stressful military experience or avoiding having feelings related
to it and avoiding activities or situations because they reminded you of a stressful military
experience). The emotional numbing score consisted of the combined score on three items (loss
of interest in activities that you used to enjoy, feeling distant or cut off from other people, and
feeling emotionally numb or being unable to have loving feelings for those close to you).
Adherence. I examined adherence using two operational definitions. First, because
treatment modalities varied in the number of sessions veterans were expected to attend, I defined
adherence as the percentage (range 0-100) of scheduled appointments that veterans attended,
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rather than the number of appointments attended. In the time-limited therapy modalities (e.g.,
psychoeducational group, group-based exposure therapy) veterans assigned to the treatment were
informed about the duration and modality of treatment prior to the first session.
To facilitate comparison of results from this study to those in the literature, I also
operationalized adherence as completion versus noncompletion. However, this was complicated
because this data was drawn from a real-world practice setting in which veterans could receive
multiple treatments, which could be time-limited (i.e., exposure-based or nonexposure-based
treatments), time-unlimited/less clearly defined, or a combination of both types of treatment. A
veteran was considered to have completed treatment if he or she attended 80% or more of the
scheduled sessions (e.g., 11/13 sessions). This definition is consistent with what has been
deemed necessary for significant improvements in both general psychological symptoms and
PTSD symptoms specifically (Barrett et al., 2008; Hansen, Lambert, Forman, 2002; Schnurr, et
al., 2003). If a veteran was enrolled in two (N=29) or three separate treatments (N=3), then the
veteran needed to attend 80% of all treatments to be counted as a completer. If a veteran only
received the psychoeducation group, then he or she needed to attend all of the sessions (4 or 8
sessions) to be coded as a completer.
Intake interview. Several variables used as covariates in this study were coded from the
intake interview. More specifically, childhood discipline problems were coded as present or
absent. The percentage of PTSD service-connection (i.e., the PTSD disability rating based on the
level of social and occupational impairment associated with military-related PTSD) was also
used as a covariate.
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Data Analytic Plan
Data were entered into SPSS 17.0 for Windows, checked, and cleaned. Further, the data
were assessed for the presence of outliers and threats to normality. I used hierarchical multiple
regression to examine the relationship between avoidance/emotional numbing severity total score
and percentage of therapy sessions attended. My core hypothesis was that severity of
avoidance/numbing symptoms would significantly predict adherence to treatment, above and
beyond demographic variables, measures of other psychopathology, clinical/treatment variables,
and measures of PTSD re-experiencing and hyperarousal symptoms. Specifically, the more
severe the avoidance/numbing symptoms, the less adherent the patient would be to therapy. In
this multiple regression analysis, the independent variable was PCL-M avoidance/emotional
numbing criterion score and the dependent variable was percentage of scheduled psychotherapy
sessions attended. Employment status, marital status, depression, consequences of alcohol and
drug use, composite score of PTSD-re-experiencing and hyperarousal symptoms, discipline
problems, percentage of PTSD service-connection, quality of life score, the presence/absence of
violence/anger, whether or not a veteran received exposure-based therapy, and whether a veteran
received time-limited treatment served as covariates.
In order to further explore the hypothesized relationship between avoidance/emotional
numbing symptoms and psychotherapy adherence, I separately examined the relationship
between avoidance symptoms and emotional numbing symptoms and adherence using multiple
regression. Lastly, to facilitate comparison of the results of this study with those in the literature,
I coded the psychotherapy adherence variable as completion/noncompletion and ran three
logistic regressions with completion/noncompletion as the outcome variable and PTSD severity
composite score, depression, exposure-based treatment, PCL avoidance and emotional numbing
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symptoms/avoidance symptoms only, and emotional numbing symptoms only, respectively, as
predictors.
Power Analysis
A priori power analyses indicated that I would have an 88% chance of detecting a
significant, medium effect (R2 = .05) in tests of the association between avoidance and
psychotherapy adherence with a sample of 200 veterans. The final sample in the analyses
included 137 veterans; therefore, I had a 72% chance of detecting a significant, medium
association (R2 = .05) between severity of the avoidance/emotional numbing scores and
percentage of therapy sessions attended.
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CHAPTER 3.
RESULTS
Data Screening
Initial analyses involved screening data to identify outliers, missing values, or atypical
distributions. Screening analyses were conducted in accordance with Tabachnick and Fidell
(2001) using SPSS 17.0. As recommended by Tabachnick and Fidell (2001), SPSS Missing
Values Analysis (SPSS MVA) was used to impute missing values for continuous, but not
dichotomous, variables.
Veterans whose values fell outside the whiskers of boxplots for measured variables were
identified as outliers. Data from 11 veterans with outlier scores on more than one variable were
excluded from the dataset. For veterans with only one outlier score, values were changed to
equal the next most extreme value in the distribution (Tabachnick & Fidell, 2001). This
adjustment was necessary for the PCL-M hyperarousal symptom cluster score, but not for other
variables.
Continuous variables were also examined for normality, linearity, homoscedasticity, and
internal consistency. All variables fit a normal distribution; skewness (absolute value less than 3)
and kurtosis (absolute values less than 10) statistics were within recommended limits for each
examined variable (Kline, 1998). Linearity and homoscedasticity were examined by inspecting
residual plots and appeared acceptable for all variables, with none violating the assumptions of
regression. Finally, measures were assessed for internal consistency, using Cronbach’s alpha. All
measures used in these analyses demonstrated acceptable internal consistency (α > .70).
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Correlations
Correlations among all predictor and outcome variables were examined (see Table 4). Results
were used to inform the selection of covariates for core analyses. Childhood discipline problems
and time-limited therapy were significantly related to psychotherapy adherence (p < .05);
therefore they were chosen as covariates for regression analyses focused on adherence.
Regression Analyses
Three hierarchical multiple regression analyses were conducted using SPSS
REGRESSION to examine the hypothesized relationship between the independent variable,
avoidance and emotional numbing, and the dependent variable, psychotherapy adherence.
Missing covariate data regarding childhood discipline problems, PTSD service-connection, and
marital status led to the exclusion of data from 23 participants from the original 160 veterans in
the sample. Data from 137 veterans were included in the regression analyses.
In the first multiple regression analysis, the PCL-M total avoidance/emotional numbing
cluster score served as a predictor of treatment adherence. I then parsed the avoidance/emotional
numbing cluster score into separate PCL-M avoidance symptom scores and PCL-M emotional
numbing symptom scores, because of controversy in the literature about whether avoidance and
emotional numbing constitute a single, unitary cluster of symptoms (Litz, 1992; Lancaster,
Melka, Rodriguez, 2009). The avoidance score consisted of the total score on the two items that
explicitly focused on avoidance (avoiding thinking about or talking about a stressful military
experience or avoiding having feelings related to it and avoiding activities or situations because
they reminded you of a stressful military experience).
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Table 4: Correlations of predictor and outcome variables.
1.
Therapy
adherence
Completion of
therapy
PCL-M
avoidance &
emotional
numbing score
PCL-M
avoidance
symptoms only
PCL-M
emotional
numbing
symptoms only
Marital status
Days Employed
at Admission
Discipline
problems
Current medical
treatment
PTSD service
connection
Depression
score
Quality of Life
score
Violence and
Anger
PCL-M reexperiencing &
hyperarousal
symptom
composite
Alcohol abuse
Drug Abuse
Exposure
therapy
Time limited
therapy

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

18.

1.00
.58**

1.00

-.07

.05

1.00

.01

.11

.70**

1.00

-.07

.11

.87**

.42**

1.00

.03

-.02

-.17*

-.14

-.15

.13

.08

**

-.20*

-.10

-.09

-.07

.08

.10

.15

-.15

.00

.04

-.05

-.15

.02

1.00

.18*

.06

.03

-.11

-.06

1.00

.03

.13

.01

-.05

-.18*

.00

.19*

1.00

.13

.72**

.42**

.69**

-.09

-.33**

-.01

.21*

.06

1.00

-.10

-.14

-.58**

-.36**

-.61**

.11

.33**

.00

-.22**

-.09

-.67**

1.00

-.02

.04

.10

.04

.14

-.13

-.05

.11

-.03

-.05

.18*

-.11

1.00

-.02

.04

.66**

.52**

.57**

-.13

-.39**

-.23**

.13

.02

.65**

-.44**

.25**

1.00

.01

.00

.00

.01

.03

-.04

.03

-.04

-.02

-.03

-.06

.05

.07

.12

1.00

.14

*

.20

.09

-.04

-.11

-.09

.04

.11

.05

-.01

.08

.14

.21**

1.00

-.07

.07

-.02

-.04

.14

.09

-.05

.01

-.12

.08

.12

.00

.01

-.13

1.00

.02

.05

.06

.02

-.03

.16

-.01

.06

-.07

.01

.08

.03

.11

-.12

.61**

.14
-.16*

**

.24

.09

-.35

1.00
1.00

-.05

-.28

**

.03

-.11

-.38

**

1.00
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The emotional numbing score consisted of the combined score on three items (loss of interest in
activities that you used to enjoy, feeling distant or cut off from other people, and feeling
emotionally numb or being unable to have loving feelings for those close to you). These scores
each served as predictors of adherence in exploratory analyses.
Avoidance and emotional numbing total score. In this regression analysis, the overall
model with all of the independent variables in the equation significantly predicted psychotherapy
adherence, R= .49, F(13, 123) = 3.01, p < .01. At step 1, when the covariates (employment
status, marital status, depression, consequences of alcohol and drug use, composite score of
PTSD-re-experiencing and hyperarousal symptoms, discipline problems, percentage of PTSD
service-connection, quality of life score, the presence/absence of violence/anger, whether or not
a veteran received exposure therapy, and whether a veteran received time-limited treatment)
were entered, the model was significant, R2 = .23, F (12, 124) = 3.12, p < .01. At step 2, when
avoidance/emotional numbing symptom score was added, the model remained significant, R2 =
.24, F (13, 123) = 3.01, p < .01. However, addition of avoidance/emotional numbing symptoms
to the regression equation did not result in a significant increase in R2 (ΔR2 = .01, p=.21).
Further, avoidance and emotional numbing symptom score did not have a significant
independent association with psychotherapy adherence, B = -.01, SE B = .01, t = -1.26, p = .21.
Several covariates, in contrast, significantly and independently predicted psychotherapy
adherence. The following covariates were negatively and significantly related to psychotherapy
adherence: discipline problems (B = -.20, SE B = .07, t = -2.83, p = .01), PTSD serviceconnection (B = .00, SE B = .002, t = -2.18, p =. 03), and having time-limited therapy (B = -.23,
SE B = .07, t = -3.05, p = .003). Having received exposure therapy was positively and
significantly associated with psychotherapy adherence (B = .22, SE B = .07, t = 3.21, p = .002).
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Avoidance only symptoms. In this regression analysis, the overall model with all of the
independent variables in the equation significantly predicted psychotherapy adherence, R = .48,
F(13, 123) = 2.91, p < .01. At step 1, the entry of the covariate set yielded significant results, R2
= .23, F (12, 124) = 3.12, p < .01. Addition of avoidance symptoms to the regression equation at
step 2, however, did not result in a significant increase in R2 (ΔR2 = .003) but the model
significantly predicted adherence, R2 = .24, F (13, 123) = 2.89, p < .01. Although avoidance
symptoms were not significantly related to psychotherapy adherence, B = .01, SE B = .02, t =
0.74, p = .46, several covariates significantly and independently predicted psychotherapy
adherence. The following covariates were negatively and significantly related to psychotherapy
adherence in this model: discipline problems (B = -.20, SE B = .07, t = -2.85, p = .01), PTSD
service-connection (B = .00, SE B = .002, t = -2.17, p =. 03), endorsing drug abuse (B = -.38, SE
B = .19, t = -2.03, p = .03), and having time-limited therapy (B = -.23, SE B = .07, t = -3.10, p =
.002). Having received exposure therapy was positively and significantly associated with
psychotherapy adherence (B = .22, SE B = .07, t = 3.16, p = .002).
Emotional numbing symptoms. In this regression analysis, the overall model with all of
the independent variables in the equation significantly predicted psychotherapy adherence, R =
.52, F(13, 123) = 3.51, p < .01 (see Table 5). When the covariates were entered at step 1, results
were significant, R2 = .23, F (12, 124) = 3.12, p < .01. The model remained significant when
emotional numbing symptom score was added at step 2, R2 = .27, Finc (1, 123) = 6.53, p < .05.
Addition of emotional numbing symptom score to the regression equation resulted in a
significant increase in R2 (ΔR2 = .04), and results indicated that emotional numbing symptoms
were significantly and negatively related to psychotherapy adherence, B = -.03, SE B = .01, t = 2.56, p = .01. Several covariates also significantly and independently predicted psychotherapy
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adherence in this analysis. The following covariates were negatively and significantly related to
psychotherapy adherence: discipline problems (B = -.21, SE B = .07, t = -2.97, p = .004), PTSD
service-connection (B = .00, SE B = .002, t = -2.36, p =. 02), quality of life score (B = -.01, SE B
= .00, t = -2.17, p = .03), drug abuse (B = -.37, SE B = .18, t = -2.07, p = .04), and having timelimited therapy (B = -.22, SE B = .07, t = -3.02, p = .003). Having received exposure therapy was
positively and significantly associated with psychotherapy adherence (B = .23, SE B = .07, t =
3.42, p = .001).
Table 5: Regression table with emotional numbing symptoms predicting adherence
Variable
β
B
SE B
Step 1
PTSD severity composite
-0.01
0.01
-0.10
Discipline problems
-0.20
0.07
-0.25**
PTSD service connection
0.00
0.00
-0.17*
Depression
0.00
0.01
0.05
Quality of life
-0.01
0.00
-0.16
Days employed
0.00
0.00
0.05
Marital status
-0.03
0.06
-0.04
Alcohol abuse
0.06
0.06
0.07
Drug abuse
-0.35
0.18
-0.16
Violence and anger
0.01
0.08
0.01
Exposure treatment
0.22
0.07
0.33**
Time-limited treatment
-0.23
0.07
-0.32**

ΔR2

.23
Step 2
PTSD severity composite
Discipline problems
PTSD service connection
Depression
Quality of life
Days employed
Marital status
Alcohol abuse
Drug abuse
Violence and anger
Exposure treatment
Time-limited treatment
Emotional numbing symptom score

0.00
-0.21
0.00
0.01
-0.01
0.00
-0.04
0.06
-0.37
0.00
0.23
-0.22
-0.03

0.01
0.07
0.00
0.01
0.00
0.00
0.05
0.06
0.18
0.08
0.07
0.07
0.01

-0.06
-0.26**
-0.19**
0.17
-0.23*
0.02
-0.06
0.08
-0.17*
0.00
0.34**
-0.30**
-0.30**
.04
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Exploratory Analyses
To facilitate comparison of the present results with findings in the PTSD literature, where
adherence has typically been defined dichotomously as completion vs. drop out, I used logistic
regression to examine whether PCL-M avoidance and emotional numbing symptom score was
significantly related to treatment completion. I conducted three separate logistic regression
analyses, one with avoidance and emotional numbing total score as the predictor variable, one
with the avoidance only score as the predictor variable, and the last with the emotional numbing
only score as the predictor variable. Assumptions of logistic regressions were checked and no
violations were found. Due to the limited number of veterans who completed treatment (N=42;
26% of the sample), only four covariates were selected for the analyses (Tabachnick & Fidell,
2001). PTSD severity composite score was chosen to control for PTSD symptom severity.
Depression was also selected as a covariate due to the frequent comorbidity of this disorder with
PTSD. Lastly, exposure-based treatment was selected as a covariate because it was significantly
related to completion of therapy (see Table 4). This variable was coded dichotomously, with
absence of the exposure-based treatment used as the reference category. The predictor variable
for each analysis (PCL-M avoidance and emotional numbing score, avoidance only score, and
emotional numbing only score, respectively) was entered into the second block of the logistic
regression.
Avoidance and emotional numbing score. The full model with all of the predictors (PTSD
severity composite score, having received exposure-based therapy, depression score, and PCL-M
avoidance and emotional numbing score) included was statistically reliable, χ2 (4, N=160) =
17.15, p <.05. This indicates that the predictors as a set distinguish between veterans who
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completed and those who did not complete therapy. Table 6 displays regression coefficients,
Wald statistics, odds ratios, and 95% confidence intervals for odds ratios for each predictor.
Table 6: Logistic regression with PCL-M avoidance/emotional numbing score predicting
treatment completion/dropout
Variable
B
Wald
Exp(B)
SE
df
p
PTSD composite
-0.03
0.04
0.82
1
.37
0.97
Depression score
0.10
0.05
4.60
1
.03
1.11
Exposure-based treatment
1.40
0.40
12.09
1
.001
4.06
Avoidance and emotional
0.00
0.05
0.00
1
.99
1.00
numbing score
Constant
-3.07
1.19
6.70
1
.01
0.05
Having received exposure-based treatment was the strongest predictor of therapy completion (z =
12.09, p < .01; OR = 4.06); indeed, participants who received exposure therapy were four times
as likely as peers who did not receive exposure to complete treatment. Depression scores were
also related to psychotherapy completion, although the relationship was weaker than that for
exposure therapy (z = 4.60, p < .05; OR = 1.11). PCL-M total avoidance and emotional numbing
score was not significantly related to completion of therapy (p = .99). Similar results were
obtained when PCL-M avoidance only score and the PCL-M emotional numbing only scores
were used as predictors in the logistic regression (see Tables 7 and 8 for results).
Table 7: Logistic regression with PCL-M avoidance only score predicting treatment
completion/dropout
Variable
B
Wald
SE
df
p
PTSD composite
-0.05
0.04
1.55
1
.21
Depression score
0.10
0.04
5.35
1
.02
Exposure-based treatment
1.37
0.41
11.39
1
.001
Avoidance and emotional
0.11
0.12
0.91
1
.34
numbing score
Constant
-3.29
1.22
7.31
1
.01
*Dependent variable was PCL-M avoidance only score.

Exp(B)
0.96
1.10
3.93
1.12
0.04
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Table 8: Logistic regression with PCL-M emotional numbing score predicting treatment
completion
Variable
B
Wald
Exp(B)
SE
df
p
PTSD composite
-0.04
0.04
1.26
1
.26
0.96
Depression score
0.09
0.05
3.53
1
.06
1.10
Exposure-based treatment
1.39
0.40
11.92
1
.001
4.03
Avoidance and emotional
0.06
0.10
0.42
1
.52
1.06
numbing score
Constant
-3.20
1.20
7.06
1
.01
0.04
*Dependent variable was PCL-M emotional numbing only score.
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CHAPTER 4.
DISCUSSION
This study was designed to examine adherence to psychotherapy in a circumscribed
population of veterans. The study focused explicitly on veterans who had returned from
campaigns in Iraq and Afghanistan, been diagnosed with PTSD, and had been offered treatment
for their psychological symptoms in a PTSD specialty clinic. The research to date in this domain
has been limited by several factors, including inconsistent and unclear definitions of adherence, a
failure to treat adherence as a primary outcome variable, and a lack of theory guiding selection of
variables important to adherence. The present study represents an effort to address these
limitations by focusing specifically on adherence, clearly defined in two ways: the percentage of
scheduled sessions attended and completion/noncompletion of therapy. Additional strengths of
the study include the use of an exhaustive archival database with data collected from a real-world
practice setting and the effort to base predictions on a theoretical framework.
Based on Ehlers and Clark’s (2000) and Foa and Kozak’s (1986) models of PTSD, in
which avoidance and emotional numbing symptoms are thought to contribute to the development
and maintenance of PTSD symptoms and to impede engagement in psychotherapy, I
hypothesized that avoidance and emotional numbing symptoms, as measured using the PCL-M, a
self-report measure of PTSD symptoms (Weathers et al, 1993), would be negatively and
significantly related to psychotherapy adherence. This primary hypothesis received only partial
support in the context of exploratory analyses, regardless of whether adherence was defined
continuously or dichotomously. Specifically, tests of the core hypothesis that scores on a
combined measure of these two symptom types would predict adherence yielded null findings;
however, when the two symptom types were examined separately in exploratory analyses, there
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was evidence of a significant and negative relationship between emotional numbing symptom
score and treatment adherence.
Previous research has produced mixed results regarding avoidance/numbing symptoms as
predictors of adherence in other veteran samples (e.g., Creamer, Elliott, Forbes, Biddle, &
Hawthorne, 2006; Glynn et al., 1999; Kutter, Wolf, & McKeever, 2004). Variability in
definitions of adherence across studies may contribute to inconsistencies in this literature. When
Hatchett and Park (2003) operationalized dropout in four different ways for the same sample,
rates varied dramatically, ranging from 17.6 to 53.1%. Thus individuals defined as completers
according to one definition might not qualify according to other definitions. To address this
problem, Hatchett and Park (2003) recommend defining dropout based on an objective measure
assessing therapy outcome such as a measure of psychological symptoms completed at each
therapy session.
Analyses yielded differing results in the present study, depending on how adherence was
defined. Each definition offered some advantages; defining adherence as the percentage of
scheduled appointments attended provided a way to compare participants enrolled in treatments
that varied in length and modality, which is reflective of real-world practice. In contrast, defining
treatment completion as a dichotomous variable permitted more direct comparison with findings
from prior studies. Further, this definition had an empirical basis: dose-response research
(Hansen et al., 2002) indicates that at least 11 to 13 sessions of evidence-based treatment are
necessary for significant symptoms reduction, and research on PTSD in veterans has indicated
that 80% adherence is necessary to reduce PTSD symptoms (Schnurr et al., 2003). Notably, this
empirically-based definition provided a conservative categorization of therapy completion.
Specifically, any veteran who left therapy before attending 11 sessions was considered a therapy
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noncompleter. It is possible that some veterans who did not attend at least 11 sessions would be
better described as completers; for example, some may have experienced significant symptoms
reduction prior to completing 11 sessions and thus may have left therapy due to satisfaction with
their psychological health. Notably, the only significant association between a hypothesized
predictor (emotional numbing score) and adherence emerged when adherence was defined
continuously; neither avoidance, nor numbing, nor combined scores predicted adherence defined
dichotomously. This suggests that there may be value in using multiple definitions of adherence
in a single study.
Another reason that the literature on predictors of adherence in veterans has yielded
mixed findings may be that studies vary in the treatments offered and thus their findings reflect
adherence patterns for only those treatments that were available. Further, most current PTSD
treatment outcome research involves tightly controlled trials of clearly time-limited treatments.
The present study, in contrast, included a wide range of treatments, some time-limited and others
more open-ended. Such real-world approaches have received little attention in the literature on
PTSD and adherence, although at least one study that Zayfert and colleagues (2005) conducted
examined predictors of adherence to both individual and group-based CBT for PTSD in a sample
assigned to treatments based on practical factors such as third party reimbursement, scheduling
needs, and health issues. This study, however, also yielded findings that were only partially
consistent with the present results; Zayfert and colleagues (2005) found that participants who
dropped out had significantly higher avoidance and emotional numbing symptom scores,
hyperarousal, depression, and more impaired social functioning than did participants who
completed treatment.
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Exploratory analyses in which PCL-M avoidance symptoms and PCL-M emotional
numbing symptoms served as separate predictor variables revealed interesting results.
Specifically, although no significant relationship was evident between avoidance and adherence,
emotional numbing symptom score was significantly and negatively associated with
psychotherapy adherence even after controlling for covariates. To date, this is the first study of
psychotherapy adherence in veterans with PTSD that has examined avoidance and emotional
numbing symptoms separately and the present findings suggest that the constructs of avoidance
and emotional numbing may warrant individual attention in treatment outcome research.
Notably, associations between emotional numbing scores and adherence were enhanced
when VAMSTA Depression scores were covaried. Given the strong bivariate correlation
between VAMSTA Depression and emotional numbing symptom scores and the relatively weak
bivariate correlation between emotional numbing scores and adherence (see Table 4), it is
possible that depression score served as a suppressor variable in data analyses (Kline, 1998).
This suggests that aspects of emotional numbing that are distinct from depression are particularly
predictive of failure to adhere to treatment. Further research examining emotional numbing as a
multifaceted construct and the relationships of these facets with adherence could help elucidate
this finding.
There are several possible reasons that veterans with higher levels of emotional numbing
symptoms, considered “cardinal signs” of PTSD (Litz, 1992), may be especially likely to
discontinue treatment prematurely. Litz (1992) has proposed that trauma-induced changes in
assumptions about safety, predictability, control, and interpersonal relationships can lead to an
inflexible and maladaptive pattern of emotion suppression, aimed at avoiding activation of
trauma-related memories. This chronic emotion suppression, in turn, may interfere with the
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formation of intimate relationships. Thus, veterans with high levels of emotional numbing may
have particular difficulty connecting with clinicians and other group members in treatment
settings, which may lead to noncompletion of therapy. Indeed, emotional numbing has been
shown to be negatively associated with perceived social support in relationships (Beck, Grant,
Clapp, & Palyo, 2008) and perceived quality of relationships with family members (Ruscio,
Weathers, King, & King, 2002).
Additionally, in light of evidence that emotional numbing is closely linked to chronic
hyperarousal (Badura, 2003; Litz, Schlenger, Weathers, Caddell, Fairbank, & La Vange,, 1997),
Badura (2003) has speculated that emotional numbing, along with the related construct of
alexithymia, functions as an avoidant coping strategy designed to reduce hyperarousal and reexperiencing symptoms. Individuals who report high levels of emotional numbing may therefore
be especially likely to drop out of treatments that elicit arousal and re-experiencing symptoms,
such as flashbacks. It is also plausible, although as yet unexplored in the literature, that this
cluster of PTSD symptoms may serve as a marker of disorder severity. Consistent with this idea
are case reports that more severely affected individuals find treatment more challenging or
aversive than do less severely affected peers and may thus be more resistant to changing their
styles of coping with PTSD symptoms and emotionally processing the traumatic event(s) as is
expected in the context of psychotherapy (Jaycox & Foa, 1996). Although research has been
conducted on correlates of emotional numbing with other symptoms, few studies have focused
on emotional numbing and treatment outcomes or treatment adherence. Further research needs to
continue to explore the potential role of emotional numbing and treatment adherence
independent of the avoidance symptoms of PTSD.
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Not surprisingly several covariates in the analyses were consistently and significantly
related to adherence. Further discussion of several salient covariate findings will follow. These
results are consistent with the behavioral model of service utilization developed by Andersen
(1995) in which three types of factors (predisposing or background factors, enabling factors, and
need factors) interact to predict use of medical or mental health services. Predisposing factors are
those that exist before the onset of illness and include demographic characteristics, health beliefs,
and expectations. Enabling factors are those that facilitate or impede service use including
income, insurance, and family involvement/social support. Need factors include diagnosis,
symptoms, comorbidity, and expected length of treatment. Of the covariates included in
regression analyses in the present study, variables representing all three factors significantly
predicted adherence to therapy. Specifically, when adherence was defined as a percentage of
psychotherapy sessions attended, endorsement of childhood discipline problems, drug abuse,
PTSD service-connection, and having received time-limited therapy were consistently related to
psychotherapy non-adherence. In contrast, having received exposure-based therapy and, in one
analysis, quality of life, were related to increased psychotherapy adherence. These results
indicate that predisposing, enabling, and need factors may be important to examine concurrently
when examining treatment adherence in veterans with PTSD.
One of the most consistent findings in the present study is that receipt of exposure-based
therapy predicts psychotherapy adherence, regardless of how adherence is defined. This finding
merits cautious interpretation, however, because veterans were not randomly assigned to
therapies. Instead, they were assigned to treatment modalities based on real world practice issues
such as what treatments were available, the veteran’s ability to attend therapy, and the treatment
team’s impression of what therapy would be most beneficial. It is not possible to determine
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whether treatment assignment was biased; however, it is possible that higher functioning
veterans who were motivated for treatment were more likely to be assigned to exposure therapies
than were less motivated or lower functioning peers.
Nonetheless, although treatment assignment was not random in this study, the finding
that receiving exposure therapy is positively related to adherence is consistent with earlier
research. For example, Hembree and colleagues (2003) found that, contrary to popular belief,
exposure therapy does not lead to higher drop out rates than do other types of CBT. In fact,
exposure therapy may facilitate treatment adherence and completion through emotional
processing, cognitive restructuring, and, given its typically brief duration, a quick decrease of
PTSD symptoms (Bradley et al, 2005; Foa & Kozak, 1986; Jaycox, Foa, & Morral, 1998). There
is also the concern that exposure therapy is more aversive to individuals and exacerbates
symptoms to a degree leading them to drop out of treatment (Pitman et al, 1991); however,
research has found that even when symptoms were exacerbated, individuals had similar
improvements in symptoms post-treatment to those whose symptoms were not exacerbated and
drop out was not associated with symptom exacerbation (Foa et al, 2002).
Findings of an inverse relationship between drug abuse and adherence are also consistent
with results of other studies, which reliably show that PTSD patients who struggle with
comorbid substance abuse or dependence are at elevated risk for dropping out of treatment
(Riggs, Rukstalis, Volpicelli, Kalmanson, & Foa; 2003; van Minnen, et al., 2002). More difficult
to interpret, based on the existing literature, is the finding of a relationship between childhood
discipline problems and psychotherapy non-adherence. Although results of one study suggest
that individuals high in “reactance” and thus less likely to follow direction from others, may do
better than more compliant peers in nondirective therapies (Karno, Beutler, & Harwood, 2002), a
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second study found adolescent clients self-reported high rates of delinquency to be associated
with drop out of treatment more often than when clients were engaging in less delinquency
(Baruch, Vrouva, & Fearon, 2009).
This study had several strengths. First, it focused on a circumscribed sample of veterans
who recently returned from operations in Iraq and Afghanistan. PTSD appears to be a common
concern in this group of veterans, many of whom access evidence-based services soon after
returning from combat. It remains unclear, however, why a sizable proportion of these veterans
fail to complete treatment and the present study provides a theoretically driven examination of
several potential predictive factors. Second, the present data were collected in a real-world
practice setting instead of a randomized control trial of psychotherapy, which facilitates broader
generalization of results.
In addition to these strengths, however, there were also several limitations. We lacked
data regarding how long veterans waited prior to receiving therapy, which has been found to
relate to more sporadic treatment attendance and treatment dropout (Cully et al., 2008; Rodolfa,
Rapaport, & Lee, 1983). Missing data was an issue in this study, which significantly affected the
sample size and may limit generalizability of these results. It was not clear whether the sizable
amount of missing data reflected unwillingness among veterans to answer some questions or a
lack of thorough data collection among clinicians, for whom the primary measure in this study
was novel at the time when the present data were gathered. It was also difficult to clearly define
adherence in this sample of veterans receiving multiple treatments, particularly because temporal
parameters were only clearly defined for a few treatments. We also lack data regarding reasons
that those participants who dropped out or left treatment; collection of such data in future studies
may facilitate interpretation of findings.
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Future research can build on the strengths of this study and address some of the
limitations. Stronger and more comprehensive theoretical models of treatment adherence in
PTSD are needed to capture the complexity of the factors that appear to impede or encourage
treatment completion. The Andersen (1995) behavioral model of health behaviors seems to hold
promise in this area. Additionally, adherence merits explicit attention in treatment outcome
studies, which have historically neglected this variable. Given that generalizability of treatment
outcome findings is likely compromised in the context of high non-adherence to treatment, it is
critical that adherence rates be described and examined. It would also be helpful for researchers
to identify the points at which individual participants drop out of treatment; however, this is
difficult if treatment is not clearly time-limited and does not progress in a regular, predictable
order, which historically is not the case (Schottenbauer, Glass, Arnkoff, Tendick, Hafter, &
Gray, 2008). Finally, before trying to identify ways to improve retention, which several
researchers have recommended (Barrett et al., 2008; Schottenbauer et al, 2008), it seems
important to more carefully characterize adherence patterns, which continue to be poorly
understood.
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Appendix A: Studies Reviewed in Bradley and Colleagues (2005) Meta-Analysis
Author(s)

Trauma Type

Dropout rate

Significant differences in adherence rates

Brom et al.,
1989

Mixed

11%

Bryant et al.,
2003

Assault &
MVA

23%

Carlson et al.,
1998
Cloitre et al.,
2002

Veterans

26%

No significant differences on SES,
multiple symptom measures, and
personality characteristics between
dropouts and completers,
Dropouts had higher depression,
avoidance, catastrophic thinking scores;
No differences in pretreatment pathology
or demographic characteristics.
Did not examine.

Abuse

21%

Devilly &
Spence, 1999
Devilly et al.,
1998
Foa et al., 1999

Mixed

28%

No differences on demographic, clinical,
or overall PTSD symptom differences
between completers and dropouts.
Did not examine.

Veterans

33%

Did not examine.

Assault

13%

Foa et al., 1991

Sexual assault

18%

Gersons,
Carlier,
Lamberts, &
van der Kolk,
2000
Glynn et al.,
1999

Police

2%

Dropouts more likely to be non-working
and in PE-SIT or SIT condition. No
differences on pretreatment
psychopathology measures.
Dropouts were more likely to have lower
incomes and were blue-collar workers.
No differences between treatment
groups.
Did not examine.

Veterans

14%

Ironson, Freud,
Strauss, &
Williams, 2002
Keane et al.,
1989
Krakow et al.,
2001

Mixed

12%

Veterans

0%

N/A

Sexual assault

25%

Control dropouts were younger than
treatment completers and used fewer
antidepressants than completers. No
differences on CAPS scores, sleep, or
frequency of nightmares.

Dropouts had higher negative PTSD
symptoms including avoidance and
numbing symptoms.
Higher dropout in prolonged exposure
than EMDR.
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Lee, Gavriel,
Drummond,
Richards, &
Greenwald,
2002
Marcus,
Marquis, &
Sakai, 1997
Marks et al.,
1998

Mixed

8%

Did not examine.

Mixed

1%

Did not examine.

Mixed

25%

Paunovic &
Ost, 2001
Resick et al.,
2002

Refugees with
mixed trauma
Rape

20%

Rothbaum,
1997
Schnurr et al.,
2003

Rape

14%

Dropouts had higher overall CAPS
severity scores at baseline and had more
prior treatment than completers.
Dropouts had more positive schemas and
had a higher education than completers.
Dropouts did not differ from completers
on overall PTSD or depression scores.
No other comparisons were mentioned.
Did not examine.

Veterans

18%

Tarrier et al.,
1999

Mixed

14%

Taylor et al.,
2003

Mixed

25%

Mixed
Vaughan,
Armstrong,
Gold, &
O'Connor, 1994
Wilson, Becker, Mixed
& Tinker, 1995
Zlotnick et al.,
Sexual abuse
1997

23%

0%

Dropouts were significantly higher in the
trauma focused group treatment
compared to the present centered group
treatment. Dropouts had lower GAF
scores, were more likely to be
unemployed, and have a history of
substance abuse or dependence. No
differences on overall CAPS severity
scores.
No differences on demographic, trauma,
or outcome measures (PTSD severity,
CAPS, intrusions or avoidance,
depression, anxiety, and general
psychopathology).
No differences on demographic
variables, type of trauma, PTSD duration
or symptoms, guilt, anger, dissociative
symptoms, or depression.
N/A

7%

Did not examine.

29%

Dropouts had higher pre-treatment
overall PTSD scores and Dissociative
Experiences Scale scores.
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Appendix B: Recent Controlled Studies of PTSD Treatment Outcomes
Author(s)
Cohen & Hien,
2006

Trauma Type
Physical or
sexual abuse
and comorbid
substance abuse
disorder
Not reported

Dropout rate
20%

Significant differences in adherence rates
Did not examine.

0%

N/A

Mixed

32%

Kubany et al,
2004

Abuse

20%

McDonagh et
al, 2005

Sexual abuse

23%

Monson et al,
2006

Veterans

17%

Power et al,
2002

Mixed

31%

Resick et al,
2008

Female victims
of interpersonal
violence

53%

Rothbaum,
Astin, &

Rape

17%

Higher dropout rate in PE than WL.
Dropouts had lower education, were
younger, and unemployed. Comorbidity,
additional trauma, and interpersonal
violence were not related to dropout.
Dropouts were less educated, younger,
more depressed, had more shame, and
had lower self-esteem. No racial or
medication differences.
Higher dropout rate from CBT than
psychoeducation and waitlist treatment.
Dropouts from CBT had more frequent
and severe childhood sexual abuse, more
severe depression and anxiety, a lower
quality of life, and more distorted
schemas.
Significant difference in dropout rates
between CPT and the waitlist condition,
with more veterans dropping out of CPT.
Did not report or examine any other
differences.
No differences on demographic or
treatment outcome measures except
dropouts had higher frequency CAPSAvoidance/emotional numbing scores.
Significant difference in dropout rates
for race and income. No differences
between CPT-C, CPT, and written
accounts; also no differences on marital
status, education level, number of crimes
in childhood, number of crimes in
adulthood, or recent number of crime
events.
Did not examine. No differences
between treatment groups.

Ehlers, Clark,
Hackmann,
McManus, &
Fennell, 2005
Foa et al, 2005
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Marsteller,
2005
Schnurr et al,
2007
Taylor et al,
2001

Female
Veterans
Road Traffic
Collision

29%
7%

Dropouts higher in PE than PC therapy.
Did not examine any other differences.
No differences on pre-treatment
measures (SCID, CAPS, PSS-SR, Motor
Vehicle Accident Scale, depression,
pain, anger, and guilt).
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Appendix C: Less Tightly Controlled Studies of PTSD Treatment Outcomes
Author(s)

Trauma Type

Dropout rate

Significant differences in adherence rates

Brady et al,
2001

PTSD and
cocaine
dependence

62%; no control
group

Chemtob et al,
1997

Vietnam
Veterans

46%

Cooper &
Clum, 1989

Vietnam
Veterans

28%

Creamer et al,
2006

Veterans

3% during
treatment; 32%
including
follow up; no
control group

Fisher et al,
1993

Childhood
sexual abuse

41%

Forbes et al.,
2005

Veterans and
peacekeepers

Frueh, Turner,
Beidel, &
Mirabella, 1996
Hyer et al, 1989

Veterans; no
control group

0% group
treatment; no
control group
27%

Treatment dropouts had significantly
higher avoidance symptoms and fewer
years of education compared to treatment
completers.
No differences between treatment
completers and dropouts on overall
PTSD severity or severity of anger, or
age and education. These researchers did
not examine potential differences on
depression or anxiety measures.
Did not find any demographic or
symptomology (i.e., depression or
behavioral avoidance scores) differences
between treatment completers and
dropouts.
Dropouts were younger, unmarried, had
higher levels of intrusion, arousal,
alcohol use, and poorer family
functioning. No differences were found
in levels of avoidance, anxiety,
depression, social functioning, somatic
symptoms, or employment status.
Mixed results on demographic
characteristics and personality profiles.
Dropouts had experienced more trauma.
N/A

Kutter et al,
2004

Veterans;
inpatient
Veterans, no
control group

Did not examine.

Did not report

Did not examine.

29%

Depression and PTSD hyperarousal
predicted initial enrollment with higher
scores positively associated with
enrollment. No demographic
characteristics or measures of
psychopathology associated with
continuation. Continuation was
associated with higher PTSD symptom
severity (each domain and overall)
scores and greater frequency of anger
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expression.
Monson,
Rodriguez, &
Warner, 2005
Munley et al,
1994

Veterans

Not reported

Vietnam
Veterans

12%

Pitman et al,
1996
Rizzo et al,
2009

Veterans; no
control group
OEF/OIF active
duty service
members
Vietnam
Veterans
Veterans

30%

Inpatient group treatment. No differences
on demographic characteristics, premilitary/military adjustment measures,
combat exposure, intelligence, or overall
PTSD severity. A few differences on
indicators of psychopathology as
measured by the MMPI. Dropouts
scoring higher than completers on the F
scale, paranoia, and hypomania.
Did not examine.

39%

Did not examine.

Not reported

Did not examine.

20% of clients
missed
appointments;
3% dropout
treatment
Not reported

More likely to miss appointments if had
a PTSD or substance abuse diagnosis.
No other differences reported or
examined.

Silver et al,
1995
Sparr et al,
1993

Tarrier et al,
2000

Mixed

van Minnen &
Hagenaars,
2002
van Minnen, et
al, 2002

Mixed; no
control group

14%

Mixed; no
control group

Study 1: 24%
Study 2: 32%

Zayfert et al,
2005

Mixed

72%; no control
group

No differences examined or reported.
Best predictor of treatment outcome was
inconsistent therapy attendance.
Dropouts had higher PTSD scores than
treatment improvers. No other
differences examined.
Study 1: No differences between
dropouts and completers.
Study 2: Dropouts were more likely to be
male, use alcohol, and have higher levels
of anxiety.
Completion of exposure therapy was
negatively related to pre-treatment PTSD
severity, CAPS avoidance and numbing,
hyperarousal, depression, and “impaired
social functioning.”
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Appendix D: Analyses of differences between veterans who received therapy and those who did
not
Crosstabs analysis
Count

Medication only

Number of comorbid
issues
0
1
2
3
Total

14
10
6
1
31

Group
Referred
out/Never returned
post-intake
5
16
15
4
40

ANOVA
Variable
Summary trauma exposure
PCL total score
Depression total score
PCL re-experiencing score

df
2
2
2
2

Therapy

Total

47
71
34
8
160

66
97
55
13
231

F

p
.000
.01
.01
.03

10.26
4.47
4.86
3.49

Summary of trauma exposure Tukey HSD
Subset for alpha = 0.05
Group
Referred out/Never returned
Medication only
Therapy
p

1

2

6.35
9.37
9.84
.86

1.00

PCL total score Tukey HSD
Subset for alpha = 0.05
Group
Referred out/Never returned
Medication only
Therapy
p

1
56.58
61.32
.14

2
61.32
62.95
.79
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Depression total score Tukey HSD
Subset for alpha = 0.05
Group
Referred out/Never returned
Medication only
Therapy
p

1
21.92
22.55
.87

2
22.55
24.85
.15
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Appendix E: Depression scale
32. Over the last 2 weeks, how often have you been bothered by any of the following problems?
a. Little interest or pleasure in doing things
 1. Not at all
 3. More than half the days
 2. Several days
 4. Nearly every day
b. Feeling down, depressed, or hopeless.
 1. Not at all
 3. More than half the days
 2. Several days
 4. Nearly every day
c. Trouble falling or staying asleep, or sleeping too much.
 1. Not at all
 3. More than half the days
 2. Several days
 4. Nearly every day
d. Feeling tired or having little energy.
 1. Not at all
 3. More than half the days
 2. Several days
 4. Nearly every day
e. Poor appetite or overeating.
 1. Not at all
 2. Several days

 3. More than half the days
 4. Nearly every day

f. Feeling bad about yourself—or that you are a failure or have let yourself or your family down.
 1. Not at all
 3. More than half the days
 2. Several days
 4. Nearly every day
g. Trouble concentrating on things, such as reading the newspaper or watching television.
 1. Not at all
 3. More than half the days
 2. Several days
 4. Nearly every day
h. Moving or speaking so slowly that other people could have noticed? Or the opposite—being so
fidgety or restless that you have been moving around a lot more than usual.
 1. Not at all
 3. More than half the days
 2. Several days
 4. Nearly every day
i. Thoughts that you would be better off dead or hurting yourself in some way.
 1. Not at all
 3. More than half the days
 2. Several days
 4. Nearly every day
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Appendix F: Alcohol and Drug use scale
43. During the past 4 months, about how often has this happened to you?
Check one answer for each item.
Once or
Never
a few
Times
0
1
a. I have been unhappy because of my drinking.


b. I have taken foolish risks when I have been drinking.
c. My physical health has been harmed by my drinking.
d. My drinking has gotten in the way of my growth as
a person.
e. My drinking has damaged my social life, popularity,
or reputation.
f. I have spent too much or lost a lot of money because
of my drinking.
g. I have had an automobile accident or injured myself
while drinking or while intoxicated.

Daily or
almost
daily
3

















































Once or
twice
a week
2

Daily or
almost
daily
3

47. During the past 4 months, about how often has this happened to you?
Check one answer for each item.
Once or
Never
a few
Times
0
1
a. Because of my drug use, I have not eaten properly.
b. I have failed to do what is expected of me because
of my drug use.
c. I have felt guilty or ashamed because of my drug use.
d. When using drugs, I have done impulsive things that
I regretted later.
e. I have had money problems because of my drug use.
f. My family has been hurt by my drug use.
g. A friendship or close relationship has been damaged
by my drug use.

Once or
twice
a week
2
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Appendix G: Quality of Life scale
83. How do you feel about:
b. The living arrangements where you live?
 1. Terrible
 4. Mixed
 2. Unhappy
 5. Mostly satisfied
 3. Mostly dissatisfied
 6. Pleased
c. The way you spend your free time?
 1. Terrible
 2. Unhappy
 3. Mostly dissatisfied

 4. Mixed
 5. Mostly satisfied
 6. Pleased

d. The amount of time you spend with other people?
 1. Terrible
 4. Mixed
 2. Unhappy
 5. Mostly satisfied
 3. Mostly dissatisfied
 6. Pleased
e. The amount of fun you have?
 1. Terrible
 2. Unhappy
 3. Mostly dissatisfied

 4. Mixed
 5. Mostly satisfied
 6. Pleased

f. The way things are in general between you and your family?
 1. Terrible
 4. Mixed
 2. Unhappy
 5. Mostly satisfied
 3. Mostly dissatisfied
 6. Pleased
g. The amount of friendship in your life?
 1. Terrible
 4. Mixed
 2. Unhappy
 5. Mostly satisfied
 3. Mostly dissatisfied
 6. Pleased
h. How comfortable and well-off you are financially?
 1. Terrible
 4. Mixed
 2. Unhappy
 5. Mostly satisfied
 3. Mostly dissatisfied
 6. Pleased

 7. Delighted

 7. Delighted

 7. Delighted

 7. Delighted

 7. Delighted

 7. Delighted

 7. Delighted

i. Your physical condition?
 1. Terrible
 2. Unhappy
 3. Mostly dissatisfied

 4. Mixed
 5. Mostly satisfied
 6. Pleased

 7. Delighted

j. Your emotional well-being?
 1. Terrible
 2. Unhappy

 4. Mixed
 5. Mostly satisfied

 7. Delighted
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 3. Mostly dissatisfied

 6. Pleased
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Appendix H: Violence & Anger scale
79. Did you do any of these during the last 4 months? (Check one answer for each item.)
 a. Destroyed property?
 b. Threatened someone with physical violence (without a weapon)?
 c. Had a physical fight with someone?
 d. Threatened someone with a weapon?
 e. Used a weapon against someone?
 f. Had thoughts of hurting someone?
 g. Were verbally abusive?
 h. Broke off contact with someone out of anger or fear of losing control?
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Appendix I: PTSD Checklist–Military Version (PCL-M)
30. INSTRUCTIONS: Below is a list of problems and complaints that veterans sometimes have in
response to stressful military experiences. Please read each one carefully, then CHECK one of the boxes
to the right to indicate how much you have been bothered by that problem IN THE PAST MONTH.
Not
A little Moderately QuiExtremely
At all
bit
a bit
1
2
3
4
5
a. Repeated, disturbing memories, thoughts,
or images of a stressful military experience?
b. Repeated, disturbing dreams of a stressful
military experience?
c. Suddenly acting or feeling as if a stressful
military experience were happening again
(as if you were reliving it)?
d. Feeling very upset when something reminded
you of a stressful military experience?
e. Having physical reactions (e.g., heart pounding,
trouble breathing, sweating) when something
reminded you of a stressful military experience?
f. Avoiding thinking about or talking about a stressful
military experience or avoiding having feelings
related to it?
g. Avoiding activities or situations because they
reminded you of a stressful military experience?
h. Trouble remembering important parts of a
stressful military experience?
i. Loss of interest in activities that you used to
enjoy?
j. Feeling distant or cut off from other people?
k. Feeling emotionally numb or being unable to
have loving feelings for those close to you?
l. Feeling as if your future somehow will be
cut short?
m. Trouble falling or staying asleep?
n. Feeling irritable or having angry outbursts?
o. Having difficulty concentrating?
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p. Being "superalert" or watchful or on guard?
q. Feeling jumpy or easily startled?

*Avoidance/emotional numbing symptoms are in bold face type.
Weathers, F.W., Huska, J.A., Keane, T.M. PCL-M for DSM-IV. Boston: National Center for
PTSD – Behavioral Science Division, 1991. This is a Government document in the public
domain.

